| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | ABCA4 ATP7A ABCA12 TCIRG1 BCS1L ABCB4 ABCC1 ABCB5 ATP1A1 ATP1A3 ATP12A ATP1A4 | 6.77e-08 | 109 | 292 | 12 | GO:0042626 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA4 ATP7A ABCF3 VWA8 ABCA12 BCS1L DDX1 ABCB4 CARNS1 ATP8B3 ABCC1 DYNC2H1 ABCB5 DHX57 ABCF2 KIFC2 HELZ2 ATP1A1 ATP1A3 ATP12A ATP1A4 | 2.38e-06 | 441 | 292 | 21 | GO:0016887 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | ATP7A SLC39A1 RYR1 ITPR1 SLC12A9 SCN1A KCNJ10 KCNMA1 SLC39A6 CNGA3 CACNA1F HCN3 GRIN2C SLC3A2 CUL5 SLC6A2 CACNA2D4 ATP1A1 ATP1A3 ATP12A ATP1A4 | 5.42e-06 | 465 | 292 | 21 | GO:0046873 |
| GeneOntologyMolecularFunction | P-type sodium:potassium-exchanging transporter activity | 8.78e-06 | 10 | 292 | 4 | GO:0005391 | |
| GeneOntologyMolecularFunction | P-type sodium transporter activity | 8.78e-06 | 10 | 292 | 4 | GO:0008554 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | ABCA4 ATP7A ABCA12 TCIRG1 BCS1L ABCB4 ABCC1 ABCB5 ATP1A1 ATP1A3 ATP12A ATP1A4 | 1.28e-05 | 178 | 292 | 12 | GO:0015399 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH10 ABCA4 ATP7A ABCF3 VWA8 ABCA12 TCIRG1 BCS1L DDX1 ABCB4 CARNS1 ATP8B3 ABCC1 DYNC2H1 ABCB5 DHX57 ABCF2 KIFC2 DNAH17 HELZ2 ATP1A1 ATP1A3 ATP12A ATP1A4 | 1.33e-05 | 614 | 292 | 24 | GO:0140657 |
| GeneOntologyMolecularFunction | P-type potassium transmembrane transporter activity | 1.36e-05 | 11 | 292 | 4 | GO:0008556 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCA4 ATP7A SLC39A1 ABCA12 SLC22A11 TCIRG1 MCL1 HTR3C SLC35B2 BCS1L RYR1 ITPR1 ABCB4 SLC12A9 SCN1A KCNJ10 SLC22A10 KCNMA1 SLC39A6 TIMM17A CNGA3 CACNA1F ABCC1 ABCB5 HCN3 GRIN2C SLC3A2 SLC4A2 CUL5 SLC6A2 CACNA2D4 ATP1A1 ATP1A3 ATP12A ATP1A4 DISP1 | 2.40e-05 | 1180 | 292 | 36 | GO:0022857 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCA4 ATP7A ABCA12 SLC22A11 TCIRG1 SLC35B2 BCS1L ABCB4 SLC12A9 SLC22A10 SLC39A6 ABCC1 ABCB5 SLC3A2 SLC4A2 SLC6A2 ATP1A1 ATP1A3 ATP12A ATP1A4 | 2.65e-05 | 477 | 292 | 20 | GO:0022804 |
| GeneOntologyMolecularFunction | calcium/calmodulin-dependent protein kinase activity | 4.01e-05 | 27 | 292 | 5 | GO:0004683 | |
| GeneOntologyMolecularFunction | transporter activity | ABCA4 ATP7A SLC39A1 ABCA12 SLC22A11 TCIRG1 MCL1 HTR3C SLC35B2 BCS1L RYR1 ITPR1 ABCB4 SLC12A9 SCN1A KCNJ10 SLC22A10 KCNMA1 SLC39A6 TIMM17A CNGA3 ATP8B3 CACNA1F ABCC1 ABCB5 HCN3 GRIN2C SLC3A2 SLC4A2 CUL5 SLC6A2 CACNA2D4 ATP1A1 ATP1A3 ATP12A ATP1A4 DISP1 | 6.68e-05 | 1289 | 292 | 37 | GO:0005215 |
| GeneOntologyMolecularFunction | retinoic acid-responsive element binding | 1.04e-04 | 7 | 292 | 3 | GO:0044323 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | ATP7A SLC39A1 TCIRG1 HTR3C RYR1 ITPR1 SLC12A9 SCN1A KCNJ10 KCNMA1 SLC39A6 CNGA3 CACNA1F HCN3 GRIN2C SLC3A2 CUL5 SLC6A2 CACNA2D4 ATP1A1 ATP1A3 ATP12A ATP1A4 | 1.27e-04 | 664 | 292 | 23 | GO:0008324 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ATP7A SLC39A1 SLC22A11 TCIRG1 RYR1 ITPR1 SLC12A9 SCN1A KCNJ10 KCNMA1 SLC39A6 CNGA3 CACNA1F ABCC1 HCN3 GRIN2C SLC3A2 SLC4A2 CUL5 SLC6A2 CACNA2D4 ATP1A1 ATP1A3 ATP12A ATP1A4 | 1.39e-04 | 758 | 292 | 25 | GO:0015318 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | ATP7A SLC39A1 TCIRG1 RYR1 ITPR1 SLC12A9 SCN1A KCNJ10 KCNMA1 SLC39A6 CNGA3 CACNA1F HCN3 GRIN2C SLC3A2 CUL5 SLC6A2 CACNA2D4 ATP1A1 ATP1A3 ATP12A ATP1A4 | 1.48e-04 | 627 | 292 | 22 | GO:0022890 |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 1.68e-04 | 36 | 292 | 5 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 1.68e-04 | 36 | 292 | 5 | GO:0015662 | |
| GeneOntologyMolecularFunction | corticosterone 18-monooxygenase activity | 2.13e-04 | 2 | 292 | 2 | GO:0047783 | |
| GeneOntologyMolecularFunction | steroid 11-beta-monooxygenase activity | 2.13e-04 | 2 | 292 | 2 | GO:0004507 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 2.87e-04 | 62 | 292 | 6 | GO:0019829 | |
| GeneOntologyMolecularFunction | ankyrin binding | 3.19e-04 | 23 | 292 | 4 | GO:0030506 | |
| GeneOntologyMolecularFunction | phosphatase activity | PLPP5 NT5C3A ACP5 PPM1M PTPN11 PTPRD CAMK2G OCRL MTMR4 MTMR14 ACP4 ATP1A1 PPTC7 | 3.31e-04 | 287 | 292 | 13 | GO:0016791 |
| GeneOntologyMolecularFunction | calcium-dependent protein serine/threonine kinase activity | 3.44e-04 | 10 | 292 | 3 | GO:0009931 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL6A5 MATN4 SLIT2 COL5A1 COL6A3 FRAS1 COL11A1 COL12A1 HMCN1 VCAN | 4.65e-04 | 188 | 292 | 10 | GO:0005201 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCA4 ATP7A ABCF3 VWA8 ABCA12 BCS1L DDX1 ABCB4 EFTUD2 CARNS1 ATP8B3 ABCC1 DYNC2H1 ABCB5 DHX57 ABCF2 KIFC2 ARL2 HELZ2 RAB15 ATP1A1 ATP1A3 ATP12A ATP1A4 | 4.71e-04 | 775 | 292 | 24 | GO:0017111 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 5.42e-04 | 46 | 292 | 5 | GO:0030020 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | GAPVD1 ABCF3 ADAM18 EVPL ITGAE ITGB6 PTPN11 PTPRD IGSF9 PLEC CNGA3 COL5A1 ITGA11 RANGAP1 ITGA10 CDH19 SLC3A2 TENM4 TENM1 CDH6 | 5.55e-04 | 599 | 292 | 20 | GO:0050839 |
| GeneOntologyMolecularFunction | Roundabout binding | 6.17e-04 | 12 | 292 | 3 | GO:0048495 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCA4 ATP7A ABCF3 PLPP5 VWA8 ABCA12 BCS1L DDX1 ABCB4 EFTUD2 CARNS1 ATP8B3 ABCC1 DYNC2H1 ABCB5 DHX57 ABCF2 KIFC2 ARL2 HELZ2 RAB15 ATP1A1 ATP1A3 ATP12A ATP1A4 | 6.30e-04 | 839 | 292 | 25 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCA4 ATP7A ABCF3 PLPP5 VWA8 ABCA12 BCS1L DDX1 ABCB4 EFTUD2 CARNS1 ATP8B3 ABCC1 DYNC2H1 ABCB5 DHX57 ABCF2 KIFC2 ARL2 HELZ2 RAB15 ATP1A1 ATP1A3 ATP12A ATP1A4 | 6.40e-04 | 840 | 292 | 25 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCA4 ATP7A ABCF3 PLPP5 VWA8 ABCA12 BCS1L DDX1 ABCB4 EFTUD2 CARNS1 ATP8B3 ABCC1 DYNC2H1 ABCB5 DHX57 ABCF2 KIFC2 ARL2 HELZ2 RAB15 ATP1A1 ATP1A3 ATP12A ATP1A4 | 6.40e-04 | 840 | 292 | 25 | GO:0016818 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ATP7A SLC39A1 TCIRG1 HTR3C RYR1 ITPR1 SLC12A9 SCN1A KCNJ10 KCNMA1 SLC39A6 CNGA3 CACNA1F HCN3 GRIN2C SLC3A2 SLC4A2 CUL5 SLC6A2 CACNA2D4 ATP1A1 ATP1A3 ATP12A ATP1A4 | 6.51e-04 | 793 | 292 | 24 | GO:0015075 |
| GeneOntologyMolecularFunction | calcium ion binding | EFCAB5 MATN4 ADGRV1 ZZEF1 RYR1 C2CD5 ITPR1 CAPN13 SLIT2 C1R PCDHB14 PCDHB2 PCDHA10 PCDHA5 CDH19 ARSA CELSR3 HMCN1 VCAN NECAB3 EFCAB7 PCDHGC3 CDH6 | 6.92e-04 | 749 | 292 | 23 | GO:0005509 |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 6.95e-04 | 28 | 292 | 4 | GO:0140326 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 7.28e-04 | 49 | 292 | 5 | GO:0140359 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH group of donors | 9.10e-04 | 30 | 292 | 4 | GO:0016645 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 9.55e-04 | 171 | 292 | 9 | GO:0015081 | |
| GeneOntologyMolecularFunction | sodium ion binding | 1.00e-03 | 14 | 292 | 3 | GO:0031402 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.07e-03 | 140 | 292 | 8 | GO:0099094 | |
| GeneOntologyMolecularFunction | pyrroline-5-carboxylate reductase activity | 1.25e-03 | 4 | 292 | 2 | GO:0004735 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.31e-03 | 33 | 292 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate phosphatase activity | 1.51e-03 | 16 | 292 | 3 | GO:0106018 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.74e-03 | 151 | 292 | 8 | GO:0015085 | |
| GeneOntologyMolecularFunction | 3'-5'-RNA exonuclease activity | 2.02e-03 | 37 | 292 | 4 | GO:0000175 | |
| GeneOntologyMolecularFunction | 2'-5'-oligoadenylate synthetase activity | 2.07e-03 | 5 | 292 | 2 | GO:0001730 | |
| GeneOntologyMolecularFunction | collagen binding involved in cell-matrix adhesion | 2.07e-03 | 5 | 292 | 2 | GO:0098639 | |
| GeneOntologyMolecularFunction | calmodulin binding | MYH10 RYR1 STRN3 CAMK4 CAMK2A CAMK2B CAMK2D CAMK2G GRM4 IQCB1 | 2.14e-03 | 230 | 292 | 10 | GO:0005516 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor | 2.15e-03 | 18 | 292 | 3 | GO:0016646 | |
| GeneOntologyMolecularFunction | protein-folding chaperone binding | 2.60e-03 | 161 | 292 | 8 | GO:0051087 | |
| GeneOntologyMolecularFunction | RNA exonuclease activity, producing 5'-phosphomonoesters | 2.71e-03 | 40 | 292 | 4 | GO:0016896 | |
| GeneOntologyMolecularFunction | calcium channel activity | 2.92e-03 | 129 | 292 | 7 | GO:0005262 | |
| GeneOntologyMolecularFunction | structural molecule activity | EPPK1 EVPL COL6A5 MATN4 NUP205 SLIT2 DLG3 PLEC SHANK1 COL5A1 COL6A3 KRT7 FRAS1 COL11A1 COL12A1 CAMK2B NUP214 SPTBN4 HMCN1 EHHADH VCAN HSPB6 SNTG1 EPB42 | 3.06e-03 | 891 | 292 | 24 | GO:0005198 |
| GeneOntologyBiologicalProcess | potassium ion homeostasis | CYP11B2 SLC12A9 KCNJ10 KCNMA1 CAMK2D ATP1A1 ATP1A3 ATP12A ATP1A4 | 1.67e-09 | 37 | 290 | 9 | GO:0055075 |
| GeneOntologyBiologicalProcess | intracellular potassium ion homeostasis | 7.97e-08 | 17 | 290 | 6 | GO:0030007 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CYLD MAGI1 CYP1B1 IL15 ABCA12 ADGRV1 ITGAE LRRC4 ITGB6 NOD2 SLIT2 PTPN11 PTPRD IGSF9 DLG3 IL4I1 SDC4 ITGA11 PCDHB14 LAG3 ITGA10 PCDHB2 NFKBID PCDHA10 PCDHA5 CDH19 SLC4A2 TENM4 RASAL3 CELSR3 HMCN1 TENM1 ASTN1 PCDHGC3 CDH6 | 3.56e-06 | 1077 | 290 | 35 | GO:0098609 |
| GeneOntologyBiologicalProcess | establishment or maintenance of transmembrane electrochemical gradient | 1.17e-05 | 11 | 290 | 4 | GO:0010248 | |
| GeneOntologyBiologicalProcess | positive regulation of vitamin D receptor signaling pathway | 5.33e-05 | 6 | 290 | 3 | GO:0070564 | |
| GeneOntologyBiologicalProcess | aldehyde metabolic process | 5.85e-05 | 95 | 290 | 8 | GO:0006081 | |
| GeneOntologyBiologicalProcess | sodium ion export across plasma membrane | 7.88e-05 | 17 | 290 | 4 | GO:0036376 | |
| GeneOntologyCellularComponent | calcium- and calmodulin-dependent protein kinase complex | 1.84e-07 | 5 | 292 | 4 | GO:0005954 | |
| GeneOntologyCellularComponent | sarcoplasm | MYH10 RYR1 ITPR1 KCNMA1 PLEC FLNC CAMK2B CAMK2D CAMK2G IFRD1 | 4.59e-06 | 114 | 292 | 10 | GO:0016528 |
| GeneOntologyCellularComponent | basal plasma membrane | EPPK1 ATP7A SLC22A11 NOD2 MET KCNJ10 SLC22A10 DLG3 PLEC ABCC1 FRMPD2 SLC3A2 SLC4A2 ATP1A1 ATP12A | 1.48e-04 | 354 | 292 | 15 | GO:0009925 |
| GeneOntologyCellularComponent | somatodendritic compartment | MYH10 ATP7A CYP11B1 CYP11B2 RTN4R SERPINF1 SARM1 LRRC4 ITPR1 UNC5A SLIT2 MET SCN1A KCNMA1 IGSF9 DLG3 PLEC CNGA3 SHANK1 CACNA1F STRN3 RANGAP1 CAMK2A CAMK2B CAMK2D HCN3 GRM4 SLC3A2 SLC6A2 SPTBN4 ASTN1 ATP1A3 SEZ6L | 2.46e-04 | 1228 | 292 | 33 | GO:0036477 |
| GeneOntologyCellularComponent | basal part of cell | EPPK1 ATP7A SLC22A11 NOD2 MET KCNJ10 SLC22A10 DLG3 PLEC ABCC1 FRMPD2 SLC3A2 SLC4A2 ATP1A1 ATP12A | 3.00e-04 | 378 | 292 | 15 | GO:0045178 |
| GeneOntologyCellularComponent | sodium:potassium-exchanging ATPase complex | 5.41e-04 | 12 | 292 | 3 | GO:0005890 | |
| GeneOntologyCellularComponent | TTT Hsp90 cochaperone complex | 5.78e-04 | 3 | 292 | 2 | GO:0110078 | |
| GeneOntologyCellularComponent | cation-transporting ATPase complex | 5.93e-04 | 49 | 292 | 5 | GO:0090533 | |
| GeneOntologyCellularComponent | anchoring junction | MAGI1 GAK EPPK1 PDGFRB EVPL ITGB6 ABCB4 SCN1A DLG3 PLEC SDC4 PRICKLE4 FLNC ITGA11 CAMK2D FRMPD2 PCDHA10 CDH19 PRX SLC3A2 SLC4A2 SPTBN4 ARL2 HMCN1 ATP1A1 PCDHGC3 CDH6 | 5.94e-04 | 976 | 292 | 27 | GO:0070161 |
| GeneOntologyCellularComponent | cell body | MYH10 ATP7A RTN4R SERPINF1 ITPR1 UNC5A SLIT2 MET SCN1A KCNJ10 KCNMA1 DLG3 CNGA3 CACNA1F STRN3 CAMK2A CAMK2B CAMK2D HCN3 SLC3A2 SLC6A2 SPTBN4 TMEM132E ASTN1 ATP1A3 SEZ6L | 6.33e-04 | 929 | 292 | 26 | GO:0044297 |
| GeneOntologyCellularComponent | axon initial segment | 6.73e-04 | 29 | 292 | 4 | GO:0043194 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | HTR3C ITGAE ITGB6 RYR1 SCN1A KCNMA1 DLG3 C5 CACNA1F ITGA11 HCN3 ITGA10 GRIN2C CDH19 SLC3A2 CACNA2D4 SNTG1 ATP1A1 ATP1A3 ATP12A ATP1A4 EFCAB7 CDH6 | 7.06e-04 | 785 | 292 | 23 | GO:0098797 |
| GeneOntologyCellularComponent | neuronal cell body | MYH10 ATP7A RTN4R SERPINF1 ITPR1 UNC5A SLIT2 MET SCN1A KCNMA1 DLG3 CNGA3 CACNA1F STRN3 CAMK2A CAMK2B CAMK2D HCN3 SLC3A2 SLC6A2 SPTBN4 ASTN1 ATP1A3 SEZ6L | 7.08e-04 | 835 | 292 | 24 | GO:0043025 |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 7.65e-04 | 139 | 292 | 8 | GO:0097733 | |
| GeneOntologyCellularComponent | transporter complex | TCIRG1 HTR3C BCS1L RYR1 SCN1A KCNJ10 KCNMA1 DLG3 CNGA3 ATP8B3 CACNA1F HCN3 GRIN2C CACNA2D4 ATP1A1 ATP1A3 ATP12A ATP1A4 | 7.80e-04 | 550 | 292 | 18 | GO:1990351 |
| GeneOntologyCellularComponent | photoreceptor outer segment | 9.52e-04 | 111 | 292 | 7 | GO:0001750 | |
| GeneOntologyCellularComponent | integrin complex | 9.85e-04 | 32 | 292 | 4 | GO:0008305 | |
| GeneOntologyCellularComponent | microbody lumen | 1.01e-03 | 55 | 292 | 5 | GO:0031907 | |
| GeneOntologyCellularComponent | peroxisomal matrix | 1.01e-03 | 55 | 292 | 5 | GO:0005782 | |
| GeneOntologyCellularComponent | ATPase dependent transmembrane transport complex | 1.01e-03 | 55 | 292 | 5 | GO:0098533 | |
| GeneOntologyCellularComponent | membrane protein complex | SYNRG SPCS2 TCIRG1 HTR3C ITGAE BCS1L ITGB6 RYR1 SEC24D AP5Z1 SCN1A KCNJ10 KCNMA1 TIMM17A DLG3 C5 CNGA3 SEL1L CACNA1F ITGA11 HCN3 ITGA10 GRIN2C CDH19 SYNE4 SLC3A2 CACNA2D4 SYNE3 SNTG1 ATP1A1 ATP1A3 ATP12A ATP1A4 EFCAB7 CDH6 EPB42 | 1.02e-03 | 1498 | 292 | 36 | GO:0098796 |
| GeneOntologyCellularComponent | photoreceptor inner segment membrane | 1.15e-03 | 4 | 292 | 2 | GO:0060342 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | TCIRG1 HTR3C BCS1L RYR1 SCN1A KCNJ10 KCNMA1 DLG3 CNGA3 CACNA1F HCN3 GRIN2C CACNA2D4 ATP1A1 ATP1A3 ATP12A ATP1A4 | 1.17e-03 | 523 | 292 | 17 | GO:1902495 |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 1.42e-03 | 153 | 292 | 8 | GO:0097731 | |
| GeneOntologyCellularComponent | sarcolemma | 1.46e-03 | 190 | 292 | 9 | GO:0042383 | |
| GeneOntologyCellularComponent | synaptic membrane | HTR3C LRRC4 ITPR1 MET PTPRD SCN1A KCNMA1 ANP32E DLG3 SHANK1 GRIN2C GRM4 SLC6A2 CELSR3 CTBP1 ACP4 ATP1A3 SEZ6L | 1.50e-03 | 583 | 292 | 18 | GO:0097060 |
| GeneOntologyCellularComponent | apical part of cell | ATP7A PDGFRB SLC22A11 TCIRG1 ABCB4 KCNJ10 KCNMA1 SLC39A6 PLEC NLRP5 ABCC1 DYNC2H1 FRMPD2 SPECC1 SLC3A2 SLC4A2 ATP1A1 ATP12A | 1.77e-03 | 592 | 292 | 18 | GO:0045177 |
| GeneOntologyCellularComponent | collagen type XI trimer | 1.89e-03 | 5 | 292 | 2 | GO:0005592 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | EPPK1 ATP7A NOD2 KCNJ10 SLC22A10 DLG3 ABCC1 FRMPD2 SLC3A2 SLC4A2 ATP1A1 ATP12A | 1.91e-03 | 320 | 292 | 12 | GO:0016323 |
| GeneOntologyCellularComponent | peroxisome | 2.04e-03 | 162 | 292 | 8 | GO:0005777 | |
| GeneOntologyCellularComponent | microbody | 2.04e-03 | 162 | 292 | 8 | GO:0042579 | |
| GeneOntologyCellularComponent | dendrite | MYH10 ATP7A CYP11B1 CYP11B2 RTN4R SARM1 LRRC4 ITPR1 SLIT2 MET KCNMA1 IGSF9 DLG3 PLEC CNGA3 SHANK1 STRN3 RANGAP1 CAMK2A CAMK2B HCN3 GRM4 ATP1A3 | 2.25e-03 | 858 | 292 | 23 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | MYH10 ATP7A CYP11B1 CYP11B2 RTN4R SARM1 LRRC4 ITPR1 SLIT2 MET KCNMA1 IGSF9 DLG3 PLEC CNGA3 SHANK1 STRN3 RANGAP1 CAMK2A CAMK2B HCN3 GRM4 ATP1A3 | 2.32e-03 | 860 | 292 | 23 | GO:0097447 |
| MousePheno | abnormal potassium level | GAK VWA8 CYP11B1 CYP11B2 DELE1 ZZEF1 RNF43 ADCY6 RYR1 ABCB4 PYCR2 IL4I1 EHHADH ATP12A | 5.20e-06 | 196 | 233 | 14 | MP:0020887 |
| MousePheno | abnormal circulating potassium level | GAK VWA8 CYP11B1 CYP11B2 DELE1 ZZEF1 RNF43 RYR1 ABCB4 PYCR2 IL4I1 EHHADH ATP12A | 5.76e-06 | 171 | 233 | 13 | MP:0002668 |
| MousePheno | abnormal potassium ion homeostasis | GAK VWA8 CYP11B1 CYP11B2 DELE1 ZZEF1 RNF43 ADCY6 RYR1 ABCB4 PYCR2 IL4I1 EHHADH ATP12A | 5.85e-06 | 198 | 233 | 14 | MP:0011978 |
| MousePheno | increased circulating potassium level | GAK VWA8 CYP11B1 CYP11B2 DELE1 ZZEF1 RNF43 RYR1 ABCB4 EHHADH | 3.43e-05 | 121 | 233 | 10 | MP:0005627 |
| MousePheno | impaired coordination | MYH10 ATP7A RTN4R ITPR1 MET KCNMA1 ANP32E PYCR2 SHANK1 CAMK4 CAMK2B GRIN2C PRX EPG5 ARSA CELSR3 MTMR14 ASTN1 ATM ATP1A3 SEZ6L | 5.13e-05 | 478 | 233 | 21 | MP:0001405 |
| MousePheno | abnormal motor coordination/balance | MYH10 ATP7A ADAM18 RTN4R KIAA0319L ITPR1 MET PTPRD SCN1A KCNJ10 KCNMA1 ANP32E YDJC PYCR2 SHANK1 CAMK4 CAMK2A CAMK2B GRIN2C PRX SLC4A2 EPG5 SPTBN4 ARSA CELSR3 MTMR14 ASTN1 ATM ATP1A3 HYDIN SEZ6L | 5.35e-05 | 873 | 233 | 31 | MP:0001516 |
| Domain | VWF_A | VWA8 COL6A5 MATN4 ITGAE ITGB6 SEC24D COL6A3 ITGA11 COL12A1 ITGA10 CACNA2D4 HMCN1 | 4.18e-08 | 99 | 289 | 12 | IPR002035 |
| Domain | VWFA | VWA8 COL6A5 MATN4 ITGAE ITGB6 COL6A3 ITGA11 COL12A1 ITGA10 CACNA2D4 HMCN1 | 5.32e-08 | 82 | 289 | 11 | PS50234 |
| Domain | CaMKII_AD | 5.62e-08 | 4 | 289 | 4 | PF08332 | |
| Domain | Ca/CaM-dep_prot_kinase-assoc | 5.62e-08 | 4 | 289 | 4 | IPR013543 | |
| Domain | VWA | VWA8 COL6A5 MATN4 ITGAE ITGB6 COL6A3 ITGA11 COL12A1 ITGA10 CACNA2D4 HMCN1 | 6.87e-08 | 84 | 289 | 11 | SM00327 |
| Domain | VWA | VWA8 COL6A5 MATN4 ITGAE COL6A3 ITGA11 COL12A1 ITGA10 CACNA2D4 | 1.80e-07 | 56 | 289 | 9 | PF00092 |
| Domain | P-type_ATPase_IIC | 8.22e-07 | 6 | 289 | 4 | IPR005775 | |
| Domain | ARM-type_fold | USP34 SARM1 ARMC2 MAP3K1 ITPR1 TELO2 IFRD2 KPNA2 INTS7 RICTOR HEATR5A IFRD1 ELMO3 CEBPZ AOPEP IQCB1 TTI1 ATM LRBA | 1.52e-06 | 339 | 289 | 19 | IPR016024 |
| Domain | ABC_transporter_CS | 3.35e-06 | 42 | 289 | 7 | IPR017871 | |
| Domain | - | 8.42e-06 | 32 | 289 | 6 | 3.40.1110.10 | |
| Domain | - | 8.42e-06 | 32 | 289 | 6 | 2.70.150.10 | |
| Domain | ABC_TRANSPORTER_2 | 8.45e-06 | 48 | 289 | 7 | PS50893 | |
| Domain | ABC_tran | 8.45e-06 | 48 | 289 | 7 | PF00005 | |
| Domain | ABC_TRANSPORTER_1 | 9.73e-06 | 49 | 289 | 7 | PS00211 | |
| Domain | ABC_transporter-like | 1.12e-05 | 50 | 289 | 7 | IPR003439 | |
| Domain | ATPase_P-typ_cyto_domN | 1.45e-05 | 35 | 289 | 6 | IPR023299 | |
| Domain | AAA+_ATPase | ABCA4 ABCF3 VWA8 ABCA12 BCS1L ABCB4 ABCC1 DYNC2H1 ABCB5 ABCF2 HELZ2 | 1.52e-05 | 144 | 289 | 11 | IPR003593 |
| Domain | AAA | ABCA4 ABCF3 VWA8 ABCA12 BCS1L ABCB4 ABCC1 DYNC2H1 ABCB5 ABCF2 HELZ2 | 1.52e-05 | 144 | 289 | 11 | SM00382 |
| Domain | ATPase_P-typ_P_site | 1.72e-05 | 36 | 289 | 6 | IPR018303 | |
| Domain | P_typ_ATPase | 1.72e-05 | 36 | 289 | 6 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.72e-05 | 36 | 289 | 6 | PS00154 | |
| Domain | - | 1.86e-05 | 74 | 289 | 8 | 3.40.50.410 | |
| Domain | ATPase_P-typ_transduc_dom_A | 2.02e-05 | 37 | 289 | 6 | IPR008250 | |
| Domain | E1-E2_ATPase | 2.02e-05 | 37 | 289 | 6 | PF00122 | |
| Domain | ARM-like | SARM1 ARMC2 TELO2 AP5Z1 IFRD2 KPNA2 RANGAP1 INTS7 RICTOR HEATR5A IFRD1 ELMO3 IQCB1 TTI1 LRBA | 2.16e-05 | 270 | 289 | 15 | IPR011989 |
| Domain | - | 3.60e-05 | 13 | 289 | 4 | 3.10.450.50 | |
| Domain | NTF2-like_dom | 6.70e-05 | 15 | 289 | 4 | IPR032710 | |
| Domain | - | 7.08e-05 | 6 | 289 | 3 | 3.90.1290.10 | |
| Domain | ATPase_P-typ_TM_dom | 8.82e-05 | 16 | 289 | 4 | IPR023298 | |
| Domain | - | 8.82e-05 | 16 | 289 | 4 | 1.20.1110.10 | |
| Domain | - | 1.13e-04 | 95 | 289 | 8 | 2.60.120.200 | |
| Domain | Cation_ATPase_C | 1.14e-04 | 17 | 289 | 4 | PF00689 | |
| Domain | ATPase_P-typ_cation-transptr_C | 1.14e-04 | 17 | 289 | 4 | IPR006068 | |
| Domain | Plectin | 1.23e-04 | 7 | 289 | 3 | PF00681 | |
| Domain | Plectin_repeat | 1.23e-04 | 7 | 289 | 3 | IPR001101 | |
| Domain | PLEC | 1.23e-04 | 7 | 289 | 3 | SM00250 | |
| Domain | Cation_ATPase_N | 1.45e-04 | 18 | 289 | 4 | PF00690 | |
| Domain | Cation_ATPase_N | 1.45e-04 | 18 | 289 | 4 | SM00831 | |
| Domain | 6-PGluconate_DH_C-like | 1.81e-04 | 19 | 289 | 4 | IPR008927 | |
| Domain | ATPase_P-typ_cation-transptr_N | 1.81e-04 | 19 | 289 | 4 | IPR004014 | |
| Domain | - | SARM1 ARMC2 TELO2 AP5Z1 IFRD2 KPNA2 INTS7 RICTOR HEATR5A IFRD1 TTI1 LRBA | 1.86e-04 | 222 | 289 | 12 | 1.25.10.10 |
| Domain | HAD-like_dom | 2.21e-04 | 79 | 289 | 7 | IPR023214 | |
| Domain | IFRD | 2.39e-04 | 2 | 289 | 2 | PF05004 | |
| Domain | Cyt_P450_mitochondrial | 2.39e-04 | 2 | 289 | 2 | IPR002399 | |
| Domain | Nuc_recep-AF1 | 2.39e-04 | 2 | 289 | 2 | PF11825 | |
| Domain | Nuc_recep-AF1 | 2.39e-04 | 2 | 289 | 2 | IPR021780 | |
| Domain | IFRD_C | 2.39e-04 | 2 | 289 | 2 | PF04836 | |
| Domain | Interferon-rel_develop_reg_C | 2.39e-04 | 2 | 289 | 2 | IPR006921 | |
| Domain | Interferon-rel_develop_reg_N | 2.39e-04 | 2 | 289 | 2 | IPR007701 | |
| Domain | Cadherin_CS | 2.94e-04 | 109 | 289 | 8 | IPR020894 | |
| Domain | CADHERIN_1 | 3.75e-04 | 113 | 289 | 8 | PS00232 | |
| Domain | Cadherin | 3.75e-04 | 113 | 289 | 8 | PF00028 | |
| Domain | - | 3.98e-04 | 114 | 289 | 8 | 2.60.40.60 | |
| Domain | CADHERIN_2 | 3.98e-04 | 114 | 289 | 8 | PS50268 | |
| Domain | Retinoid-X_rcpt/HNF4 | 4.06e-04 | 10 | 289 | 3 | IPR000003 | |
| Domain | CA | 4.22e-04 | 115 | 289 | 8 | SM00112 | |
| Domain | Cadherin-like | 4.47e-04 | 116 | 289 | 8 | IPR015919 | |
| Domain | FG-GAP | 4.67e-04 | 24 | 289 | 4 | PF01839 | |
| Domain | FG-GAP | 4.67e-04 | 24 | 289 | 4 | IPR013517 | |
| Domain | Cadherin | 5.02e-04 | 118 | 289 | 8 | IPR002126 | |
| Domain | - | KCTD9 RTN4R LRRC74A LRRC4 NOD2 SLIT2 ANP32E NLRP5 RANGAP1 PRAMEF20 LINGO2 IGFALS TMOD1 LRRC71 | 5.06e-04 | 321 | 289 | 14 | 3.80.10.10 |
| Domain | Integrin_dom | 5.50e-04 | 25 | 289 | 4 | IPR032695 | |
| Domain | L_dom-like | KCTD9 RTN4R LRRC74A LRRC4 NOD2 SLIT2 ANP32E NLRP5 RANGAP1 PRAMEF20 LINGO2 IGFALS TMOD1 LRRC71 | 6.26e-04 | 328 | 289 | 14 | IPR032675 |
| Domain | - | 7.09e-04 | 3 | 289 | 2 | 1.10.3730.10 | |
| Domain | ABC_tran_Xtn | 7.09e-04 | 3 | 289 | 2 | PF12848 | |
| Domain | ABC_tran_Xtn | 7.09e-04 | 3 | 289 | 2 | IPR032781 | |
| Domain | P5CR_dimer | 7.09e-04 | 3 | 289 | 2 | PF14748 | |
| Domain | P5CR_dimer | 7.09e-04 | 3 | 289 | 2 | IPR029036 | |
| Domain | P-loop_NTPase | MAGI1 MYH10 ABCA4 ABCF3 VWA8 ABCA12 BCS1L DDX1 ABCB4 EFTUD2 NOD2 N4BP2L2 DLG3 NLRP5 ABCC1 DYNC2H1 ABCB5 DHX57 ABCF2 KIFC2 URGCP ARL2 IQCB1 HELZ2 RAB15 HYDIN | 7.35e-04 | 848 | 289 | 26 | IPR027417 |
| Domain | Spectrin_repeat | 9.83e-04 | 29 | 289 | 4 | IPR002017 | |
| Domain | Tox-GHH_dom | 1.40e-03 | 4 | 289 | 2 | IPR028916 | |
| Domain | OAS1_C | 1.40e-03 | 4 | 289 | 2 | PF10421 | |
| Domain | KASH | 1.40e-03 | 4 | 289 | 2 | PS51049 | |
| Domain | 25A_SYNTH_3 | 1.40e-03 | 4 | 289 | 2 | PS50152 | |
| Domain | Tox-GHH | 1.40e-03 | 4 | 289 | 2 | PF15636 | |
| Domain | 2-5A_synthase | 1.40e-03 | 4 | 289 | 2 | IPR026774 | |
| Domain | KASH | 1.40e-03 | 4 | 289 | 2 | PF10541 | |
| Domain | - | 1.40e-03 | 4 | 289 | 2 | 1.10.1410.20 | |
| Domain | Ten_N | 1.40e-03 | 4 | 289 | 2 | PF06484 | |
| Domain | TENEURIN_N | 1.40e-03 | 4 | 289 | 2 | PS51361 | |
| Domain | P5CR | 1.40e-03 | 4 | 289 | 2 | PS00521 | |
| Domain | KASH | 1.40e-03 | 4 | 289 | 2 | IPR012315 | |
| Domain | Pyrroline-COOH_reductase | 1.40e-03 | 4 | 289 | 2 | IPR000304 | |
| Domain | 2-5-oligoadenylate_synth_CS | 1.40e-03 | 4 | 289 | 2 | IPR006117 | |
| Domain | 2-5-oligoAdlate_synth_1_dom2/C | 1.40e-03 | 4 | 289 | 2 | IPR018952 | |
| Domain | KASH | 1.40e-03 | 4 | 289 | 2 | SM01249 | |
| Domain | Ten_N | 1.40e-03 | 4 | 289 | 2 | IPR009471 | |
| Domain | 25A_SYNTH_1 | 1.40e-03 | 4 | 289 | 2 | PS00832 | |
| Domain | 25A_SYNTH_2 | 1.40e-03 | 4 | 289 | 2 | PS00833 | |
| Domain | SPEC | 1.44e-03 | 32 | 289 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.44e-03 | 32 | 289 | 4 | IPR018159 | |
| Domain | LRR_6 | 1.58e-03 | 55 | 289 | 5 | PF13516 | |
| Domain | EGF-like_dom | ADAM18 MATN4 SLIT2 C1R FRAS1 TENM4 CELSR3 HMCN1 VCAN TENM1 ASTN1 | 1.79e-03 | 249 | 289 | 11 | IPR000742 |
| Domain | EF-hand-dom_pair | EFCAB5 SYNRG CFAP251 LRRC74A ZZEF1 RYR1 CAPN13 SCN1A CACNA1F TBC1D8 NECAB3 EFCAB7 | 1.79e-03 | 287 | 289 | 12 | IPR011992 |
| Domain | Ion_trans_dom | 1.99e-03 | 114 | 289 | 7 | IPR005821 | |
| Domain | Ion_trans | 1.99e-03 | 114 | 289 | 7 | PF00520 | |
| Domain | Laminin_G | 2.01e-03 | 58 | 289 | 5 | IPR001791 | |
| Domain | EGF_1 | ADAM18 MATN4 ITGB6 SLIT2 C1R TENM4 CELSR3 HMCN1 VCAN TENM1 ASTN1 | 2.16e-03 | 255 | 289 | 11 | PS00022 |
| Domain | ConA-like_dom | ADGRV1 RYR1 DDX1 SLIT2 COL5A1 COL11A1 COL12A1 LGALS12 CELSR3 LRBA | 2.25e-03 | 219 | 289 | 10 | IPR013320 |
| Domain | 2-5-oligoadenylate_synth_N | 2.31e-03 | 5 | 289 | 2 | IPR006116 | |
| Pathway | REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB | 2.28e-09 | 10 | 214 | 6 | M26910 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | ATP7A ATP8B3 CAMK2A CAMK2B CAMK2D CAMK2G ATP1A1 ATP1A3 ATP12A ATP1A4 | 8.49e-09 | 55 | 214 | 10 | M971 |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | ATP7A ATP8B3 CAMK2A CAMK2B CAMK2D CAMK2G ATP1A1 ATP1A3 ATP12A ATP1A4 | 1.22e-08 | 57 | 214 | 10 | MM15643 |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION | 1.63e-08 | 21 | 214 | 7 | M27944 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 6.42e-08 | 25 | 214 | 7 | M47511 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.06e-07 | 54 | 214 | 9 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.06e-07 | 54 | 214 | 9 | MM15202 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY | 1.23e-07 | 17 | 214 | 6 | M47387 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 1.54e-07 | 41 | 214 | 8 | M512 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 5.12e-07 | 21 | 214 | 6 | M838 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 6.95e-07 | 22 | 214 | 6 | MM15104 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 7.89e-07 | 35 | 214 | 7 | MM15109 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 9.28e-07 | 23 | 214 | 6 | M27949 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 9.28e-07 | 23 | 214 | 6 | M47512 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 1.18e-06 | 37 | 214 | 7 | M749 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.22e-06 | 24 | 214 | 6 | M47509 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 1.38e-06 | 14 | 214 | 5 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 1.38e-06 | 14 | 214 | 5 | M47388 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.41e-06 | 54 | 214 | 8 | M26911 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | RPS6KA6 DLG3 KPNA2 CAMK4 CAMK2A CAMK2B CAMK2D CAMK2G GRIN2C PRKAG3 | 1.57e-06 | 94 | 214 | 10 | M2843 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.59e-06 | 25 | 214 | 6 | M47510 | |
| Pathway | WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3 | 1.91e-06 | 75 | 214 | 9 | M39568 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY | 2.04e-06 | 15 | 214 | 5 | M47385 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 3.25e-06 | 28 | 214 | 6 | M837 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 3.25e-06 | 28 | 214 | 6 | M47508 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII_CAMKK_CAMKIV_CASCASDE | 3.45e-06 | 8 | 214 | 4 | M10546 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 4.01e-06 | 44 | 214 | 7 | M39845 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY | 7.52e-06 | 19 | 214 | 5 | M47957 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 8.97e-06 | 33 | 214 | 6 | M39875 | |
| Pathway | REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR | 9.91e-06 | 20 | 214 | 5 | M17670 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 1.04e-05 | 70 | 214 | 8 | M3115 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | HTR3C ADCY6 KCNJ10 RPS6KA6 DLG3 KPNA2 CAMK4 CAMK2A CAMK2B CAMK2D CAMK2G GRIN2C PRKAG3 | 1.50e-05 | 205 | 214 | 13 | M752 |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | ATP7A TCIRG1 RYR1 ATP8B3 CAMK2A CAMK2B CAMK2D CAMK2G ATP1A1 ATP1A3 ATP12A ATP1A4 | 1.56e-05 | 176 | 214 | 12 | MM15718 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCA4 ATP7A SLC39A1 ABCA12 SLC22A11 TCIRG1 SLC35B2 ADCY6 RYR1 ABCB4 SLC39A6 SEL1L ATP8B3 ABCC1 CAMK2A CAMK2B CAMK2D CAMK2G ABCB5 SLC3A2 SLC4A2 SLC6A2 ARL2 ATP1A1 ATP1A3 ATP12A ATP1A4 | 1.91e-05 | 736 | 214 | 27 | M27287 |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | ATP7A TCIRG1 RYR1 ATP8B3 CAMK2A CAMK2B CAMK2D CAMK2G ATP1A1 ATP1A3 ATP12A ATP1A4 | 2.30e-05 | 183 | 214 | 12 | M997 |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 2.64e-05 | 103 | 214 | 9 | MM15196 | |
| Pathway | PID_IFNG_PATHWAY | 2.85e-05 | 40 | 214 | 6 | M161 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | RYR1 ITPR1 SCN1A CAMK2A CAMK2B CAMK2D CAMK2G ATP1A1 ATP1A3 ATP1A4 | 2.88e-05 | 130 | 214 | 10 | M27454 |
| Pathway | KEGG_MEDICUS_VARIANT_PAX8_PPARG_FUSION_TO_PPARG_MEDIATED_TRANSCRIPTION | 3.37e-05 | 5 | 214 | 3 | M49023 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCA4 ATP7A SLC39A1 ABCA12 TCIRG1 SLC35B2 RYR1 ABCB4 SLC39A6 SEL1L ATP8B3 ABCC1 CAMK2A CAMK2B CAMK2D CAMK2G ABCB5 SLC3A2 SLC4A2 SLC6A2 ARL2 ATP1A1 ATP1A3 ATP12A ATP1A4 | 3.94e-05 | 681 | 214 | 25 | MM14985 |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 4.98e-05 | 44 | 214 | 6 | M27934 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 6.60e-05 | 90 | 214 | 8 | M6467 | |
| Pathway | WP_VITAMIN_A1_AND_A5X_PATHWAYS | 6.67e-05 | 6 | 214 | 3 | M48097 | |
| Pathway | WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION | 7.29e-05 | 47 | 214 | 6 | M39531 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 7.29e-05 | 47 | 214 | 6 | MM14925 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | PDGFRB AVPR1B RYR1 ITPR1 CACNA1F CAMK4 CAMK2A CAMK2B CAMK2D CAMK2G GRIN2C | 8.66e-05 | 178 | 214 | 11 | M2890 |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 9.40e-05 | 121 | 214 | 9 | M39823 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 1.11e-04 | 32 | 214 | 5 | M27455 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 1.11e-04 | 32 | 214 | 5 | M27900 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 1.49e-04 | 101 | 214 | 8 | M1979 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.52e-04 | 76 | 214 | 7 | MM14867 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL6A5 MATN4 ITGAE ITGB6 CAPN13 SDC4 COL5A1 COL6A3 ITGA11 COL11A1 COL12A1 ITGA10 VCAN | 1.60e-04 | 258 | 214 | 13 | MM14572 |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 1.67e-04 | 19 | 214 | 4 | MM15473 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | HTR3C ADCY6 PTPRD KCNJ10 KCNMA1 RPS6KA6 DLG3 KPNA2 SHANK1 CAMK4 CAMK2A CAMK2B CAMK2D CAMK2G HCN3 GRIN2C PRKAG3 | 1.81e-04 | 411 | 214 | 17 | M735 |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 1.98e-04 | 36 | 214 | 5 | M39831 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL6A5 MATN4 ITGAE ITGB6 CAPN13 PLEC SDC4 COL5A1 COL6A3 ITGA11 COL11A1 COL12A1 ITGA10 VCAN | 2.00e-04 | 300 | 214 | 14 | M610 |
| Pathway | REACTOME_MUSCLE_CONTRACTION | RYR1 ITPR1 CAMK2A CAMK2B CAMK2D CAMK2G TMOD1 ATP1A1 ATP1A3 ATP1A4 | 2.13e-04 | 165 | 214 | 10 | MM15026 |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | HTR3C ADCY6 KCNJ10 RPS6KA6 DLG3 KPNA2 CAMK4 CAMK2A CAMK2B CAMK2D CAMK2G GRIN2C PRKAG3 | 2.50e-04 | 270 | 214 | 13 | M15514 |
| Pathway | KEGG_MEDICUS_REFERENCE_THYROID_HORMONE_SIGNALING_PATHWAY | 2.71e-04 | 9 | 214 | 3 | M47629 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | RYR1 ITPR1 SCN1A CAMK2A CAMK2B CAMK2D CAMK2G TMOD1 ATP1A1 ATP1A3 ATP1A4 | 2.75e-04 | 203 | 214 | 11 | M5485 |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 2.84e-04 | 84 | 214 | 7 | M7098 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 3.05e-04 | 85 | 214 | 7 | M16441 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 3.16e-04 | 61 | 214 | 6 | M27103 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | ADCY6 KCNJ10 RPS6KA6 DLG3 CAMK2A CAMK2B CAMK2D CAMK2G GRIN2C | 3.51e-04 | 144 | 214 | 9 | MM14501 |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 3.65e-04 | 23 | 214 | 4 | M47720 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 3.65e-04 | 23 | 214 | 4 | MM14953 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 3.70e-04 | 41 | 214 | 5 | MM15538 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 3.77e-04 | 63 | 214 | 6 | M27862 | |
| Pathway | WP_VITAMIN_D_METABOLISM | 3.83e-04 | 10 | 214 | 3 | M39352 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 4.08e-04 | 147 | 214 | 9 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 4.97e-04 | 151 | 214 | 9 | M39329 | |
| Pathway | REACTOME_ENDOGENOUS_STEROLS | 5.09e-04 | 25 | 214 | 4 | M11184 | |
| Pathway | WP_FRAGILE_X_SYNDROME | 5.13e-04 | 121 | 214 | 8 | M39804 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 5.16e-04 | 44 | 214 | 5 | M11911 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 5.16e-04 | 44 | 214 | 5 | M27812 | |
| Pathway | BIOCARTA_NPC_PATHWAY | 5.20e-04 | 11 | 214 | 3 | M22033 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 5.94e-04 | 26 | 214 | 4 | M47 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 6.36e-04 | 46 | 214 | 5 | M198 | |
| Pathway | KEGG_NEUROTROPHIN_SIGNALING_PATHWAY | 6.71e-04 | 126 | 214 | 8 | M16763 | |
| Pathway | REACTOME_ENDOGENOUS_STEROLS | 6.89e-04 | 27 | 214 | 4 | MM14844 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 7.24e-04 | 98 | 214 | 7 | M965 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY | 7.94e-04 | 28 | 214 | 4 | M47655 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 8.52e-04 | 49 | 214 | 5 | MM15186 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 8.67e-04 | 101 | 214 | 7 | M27253 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 9.11e-04 | 29 | 214 | 4 | MM15028 | |
| Pathway | KEGG_FOCAL_ADHESION | PDGFRB ITGB6 MET COL5A1 COL6A3 FLNC ITGA11 FLT4 COL11A1 ITGA10 | 9.32e-04 | 199 | 214 | 10 | M7253 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 9.35e-04 | 50 | 214 | 5 | MM14796 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.03e-03 | 76 | 214 | 6 | M27219 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLCN_MTORC1_SIGNALING_PATHWAY | 1.11e-03 | 14 | 214 | 3 | M47922 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 1.18e-03 | 31 | 214 | 4 | M7223 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.22e-03 | 53 | 214 | 5 | MM14566 | |
| Pathway | WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING | 1.33e-03 | 140 | 214 | 8 | M42572 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 1.63e-03 | 83 | 214 | 6 | M8728 | |
| Pathway | PID_SMAD2_3PATHWAY | 1.67e-03 | 16 | 214 | 3 | M228 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 1.67e-03 | 113 | 214 | 7 | M16817 | |
| Pathway | REACTOME_RAF_ACTIVATION | 1.68e-03 | 34 | 214 | 4 | M27556 | |
| Pathway | REACTOME_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES | 1.68e-03 | 34 | 214 | 4 | M27461 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.70e-03 | 57 | 214 | 5 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.83e-03 | 58 | 214 | 5 | M2049 | |
| Pathway | REACTOME_RAF_ACTIVATION | 1.87e-03 | 35 | 214 | 4 | MM15271 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | KCTD9 GAPVD1 FAM234A GHDC NT5C3A SARM1 SPCS2 SLC35B2 NCLN RNF43 DDX1 NUP205 SLIT2 FOXRED2 SLC12A9 TELO2 BAG6 ILVBL KPNA2 SEL1L ABCC1 RANGAP1 INTS7 DYNC2H1 CAMK2D ABCF2 NUP214 OCRL URGCP SLC3A2 SLC4A2 IFRD1 CEBPZ MTR ATP1A1 ATP1A3 | 5.96e-14 | 942 | 295 | 36 | 31073040 |
| Pubmed | USP34 CYP1B1 MYH10 GAK VWA8 NT5C3A NOL6 NCLN DDX1 ITPR1 NUP205 EFTUD2 NOD2 EVI5 TELO2 POMP PRMT5 PYCR1 ANP32E PYCR2 BAG6 ILVBL KPNA2 SEL1L COL5A1 ABCC1 PSAT1 RANGAP1 POLRMT DHX57 OAS3 ABCF2 SPECC1 SLC3A2 CUL5 CEBPZ TMOD1 CTBP1 ATM ATP1A1 | 4.90e-11 | 1440 | 295 | 40 | 30833792 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | USP34 CYP1B1 FAM234A SLC39A1 SPCS2 KIAA0319L TMTC2 SLC35B2 SSR2 NCLN ZZEF1 DDX1 ITPR1 MET FOXRED2 GLYR1 PRMT5 SLC39A6 PLXNA1 SEL1L COL5A1 ABCC1 ITGA11 FRAS1 COL12A1 SLC3A2 SLC4A2 ARSA CELSR3 TTI1 TMEM131 ATM ATP1A1 | 3.65e-09 | 1201 | 295 | 33 | 35696571 |
| Pubmed | 5.07e-09 | 4 | 295 | 4 | 10381553 | ||
| Pubmed | 5.07e-09 | 4 | 295 | 4 | 11889801 | ||
| Pubmed | Cadmium activates CaMK-II and initiates CaMK-II-dependent apoptosis in mesangial cells. | 5.07e-09 | 4 | 295 | 4 | 17367784 | |
| Pubmed | 1.03e-08 | 10 | 295 | 5 | 19776387 | ||
| Pubmed | GAK VWA8 NCLN BCS1L TELO2 PYCR1 TIMM17A PISD GMPPA ILVBL DYNC2H1 CAMK2B CAMK2D POLD2 CAMK2G ABCF2 RICTOR NUP214 VPS13D MTR TTI1 TMEM131 | 1.44e-08 | 606 | 295 | 22 | 36538041 | |
| Pubmed | Multiple genes encode the human Na+,K+-ATPase catalytic subunit. | 2.52e-08 | 5 | 295 | 4 | 3035563 | |
| Pubmed | 2.52e-08 | 5 | 295 | 4 | 14722083 | ||
| Pubmed | 2.52e-08 | 5 | 295 | 4 | 18218981 | ||
| Pubmed | Transition from reversible to persistent binding of CaMKII to postsynaptic sites and NR2B. | 2.52e-08 | 5 | 295 | 4 | 16436603 | |
| Pubmed | 2.52e-08 | 5 | 295 | 4 | 11013247 | ||
| Pubmed | 2.52e-08 | 5 | 295 | 4 | 21209221 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 SYNRG NDOR1 EPPK1 VWA8 KIAA0319L NCLN ZZEF1 RNF43 RYR1 PLEKHH3 NOD2 WIZ IFRD2 TIGD3 PLEC PLXNA1 FLNC FRAS1 MYOM3 POLRMT NUP214 SYNE4 KIFC2 TKFC SYNE3 CELSR3 MTMR14 HELZ2 LRBA | 2.57e-08 | 1105 | 295 | 30 | 35748872 |
| Pubmed | 3.20e-08 | 12 | 295 | 5 | 8665664 | ||
| Pubmed | 3.20e-08 | 12 | 295 | 5 | 12815021 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | USP34 GAPVD1 ABCF3 MC1R ZZEF1 DDX1 NUP205 EFTUD2 ABRAXAS2 SEC24D PTPN11 TELO2 PRMT5 ANP32E PLEC GMPPA BAG6 KPNA2 DPP7 FLNC STRN3 KRT7 PSAT1 RANGAP1 NAGK POLD2 ABCF2 AARSD1 CUL5 SPC24 ARL2 TKFC MTR TTI1 LRBA | 3.38e-08 | 1455 | 295 | 35 | 22863883 |
| Pubmed | Multiple kinases regulate mafA expression in the pancreatic beta cell line MIN6. | 7.51e-08 | 6 | 295 | 4 | 18948074 | |
| Pubmed | 7.51e-08 | 6 | 295 | 4 | 3036582 | ||
| Pubmed | Rad and Rad-related GTPases interact with calmodulin and calmodulin-dependent protein kinase II. | 1.74e-07 | 7 | 295 | 4 | 9115241 | |
| Pubmed | EFCAB5 MYH10 NOL6 SSR2 ADCY6 DDX1 ABCB4 NUP205 PYCR1 DLG3 PLEC PYCR2 FLNC STRN3 KRT7 RANGAP1 CAMK2B CAMK2G ABCB5 DHX57 ABCF2 PRX SLC3A2 SPTBN4 CEBPZ CIAO3 TENM1 ATM ATP1A1 ATP1A3 ATP12A ATP1A4 PCDHGC3 | 2.68e-07 | 1442 | 295 | 33 | 35575683 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | USP34 CYP1B1 GAK SLC39A1 VWA8 PDGFRB SPCS2 MCL1 NCLN BCS1L DDX1 ITPR1 EFTUD2 SLIT2 SEC24D PYCR1 SLC39A6 C1R PLEC PYCR2 BAG6 PLXNA1 ILVBL SEL1L ABCC1 FLNC OAS1 OAS3 ABCF2 SLC3A2 SLC4A2 CTBP1 ATP1A1 | 3.08e-07 | 1451 | 295 | 33 | 30550785 |
| Pubmed | 3.46e-07 | 8 | 295 | 4 | 20668654 | ||
| Pubmed | 3.46e-07 | 8 | 295 | 4 | 11264466 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | USP34 CYP1B1 FAM234A NT5C3A SARM1 TCIRG1 ADCY6 NUP205 MET PTPN11 TIMM17A PISD C5 BAG6 PLXNA1 PSAT1 DYNC2H1 OPA3 MEAK7 SLC4A2 TBC1D8 TKFC TTI1 ATM LRBA ATP12A PCDHGC3 | 4.72e-07 | 1061 | 295 | 27 | 33845483 |
| Pubmed | CYLD SYNRG MYH10 VWA8 NCLN ITPR1 MET GLYR1 SCN1A SLC39A6 DLG3 PLEC PYCR2 ALDH6A1 SHANK1 STRN3 RANGAP1 CAMK4 CAMK2A CAMK2B CAMK2D CAMK2G RICTOR SLC3A2 TENM4 KIAA1217 TENM1 ASTN1 | 5.69e-07 | 1139 | 295 | 28 | 36417873 | |
| Pubmed | 6.04e-07 | 3 | 295 | 3 | 11053444 | ||
| Pubmed | Retinoid X receptors: X-ploring their (patho)physiological functions. | 6.04e-07 | 3 | 295 | 3 | 15608692 | |
| Pubmed | Retinoid receptors trigger neuritogenesis in retinal degenerations. | 6.04e-07 | 3 | 295 | 3 | 21940995 | |
| Pubmed | 6.04e-07 | 3 | 295 | 3 | 9882483 | ||
| Pubmed | Identification of novel human tumor cell-specific CaMK-II variants. | 6.04e-07 | 3 | 295 | 3 | 9060999 | |
| Pubmed | 6.04e-07 | 3 | 295 | 3 | 10819240 | ||
| Pubmed | 6.04e-07 | 3 | 295 | 3 | 7831303 | ||
| Pubmed | Detection of retinoid X receptors using specific monoclonal and polyclonal antibodies. | 6.04e-07 | 3 | 295 | 3 | 7980510 | |
| Pubmed | Immunohistochemical detection of the retinoid X receptors alpha, beta, and gamma in human prostate. | 6.04e-07 | 3 | 295 | 3 | 12514092 | |
| Pubmed | 6.04e-07 | 3 | 295 | 3 | 8034312 | ||
| Pubmed | Identification of a VxP Targeting Signal in the Flagellar Na+ /K+ -ATPase. | 6.04e-07 | 3 | 295 | 3 | 26373354 | |
| Pubmed | 6.04e-07 | 3 | 295 | 3 | 17984374 | ||
| Pubmed | 6.04e-07 | 3 | 295 | 3 | 8799145 | ||
| Pubmed | 6.04e-07 | 3 | 295 | 3 | 20844140 | ||
| Pubmed | Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. | 6.04e-07 | 3 | 295 | 3 | 1312497 | |
| Pubmed | Pressure overload selectively up-regulates Ca2+/calmodulin-dependent protein kinase II in vivo. | 6.04e-07 | 3 | 295 | 3 | 12554746 | |
| Pubmed | 6.04e-07 | 3 | 295 | 3 | 11839661 | ||
| Pubmed | 6.18e-07 | 9 | 295 | 4 | 12660151 | ||
| Pubmed | MYH10 DHRS4 KCNJ10 ALDH6A1 SHANK1 CAMK2A CAMK2B CAMK2D DHRS4L2 CAMK2G SPECC1 TMOD1 | 8.42e-07 | 233 | 295 | 12 | 29518331 | |
| Pubmed | NOL6 NCLN ZZEF1 ADCY6 XAB2 DDX1 ITPR1 ILVBL CDC42BPG FRAS1 ARHGEF28 PARG POLRMT DHX57 RICTOR URGCP SLC4A2 CUL5 MTR PCDHGC3 | 9.04e-07 | 650 | 295 | 20 | 38777146 | |
| Pubmed | USP34 GAPVD1 MYH10 EPPK1 NOL6 XAB2 NUP205 GLYR1 PRMT5 PLEC COL5A1 FLNC RANGAP1 POLRMT DHX57 NUP214 CEBPZ HELZ2 ATM ATP1A1 | 9.70e-07 | 653 | 295 | 20 | 22586326 | |
| Pubmed | 9.93e-07 | 22 | 295 | 5 | 8894702 | ||
| Pubmed | 1.02e-06 | 10 | 295 | 4 | 28361052 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | USP34 GAPVD1 GAK SPCS2 EVPL NCLN C2CD5 NUP205 ABRAXAS2 PTPN11 PTPRD TELO2 PYCR1 PYCR2 BAG6 SEL1L FLNC NAGK POLRMT ABCF2 NUP214 SLC3A2 MTMR4 MTMR14 PPTC7 | 1.09e-06 | 974 | 295 | 25 | 28675297 |
| Pubmed | CYLD GAK ATP7A VWA8 NCLN BCS1L C2CD5 ITPR1 EFTUD2 ABRAXAS2 MET TELO2 GLYR1 PYCR1 SLC39A6 ANP32E PYCR2 BAG6 FRAS1 RANGAP1 DYNC2H1 POLRMT RICTOR SLC3A2 SLC4A2 TBC1D8 ARL2 SYNE3 CEBPZ MTR TMEM131 ATM | 1.54e-06 | 1487 | 295 | 32 | 33957083 | |
| Pubmed | Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. | 1.60e-06 | 11 | 295 | 4 | 20427287 | |
| Pubmed | EPPK1 VWA8 NOL6 ITPR1 NUP205 WIZ GLYR1 PYCR1 ILVBL KPNA2 SEL1L ABCC1 COL11A1 INTS7 DYNC2H1 CAMK4 LAG3 NUP214 KIFC2 TMOD1 ASTN1 | 2.33e-06 | 754 | 295 | 21 | 35906200 | |
| Pubmed | 2.38e-06 | 12 | 295 | 4 | 8615909 | ||
| Pubmed | Retinoic acid biosynthetic activity and retinoid receptors in the olfactory mucosa of adult mice. | 2.40e-06 | 4 | 295 | 3 | 10079186 | |
| Pubmed | 2.40e-06 | 4 | 295 | 3 | 21849490 | ||
| Pubmed | 2.40e-06 | 4 | 295 | 3 | 9804293 | ||
| Pubmed | 2.40e-06 | 4 | 295 | 3 | 2887455 | ||
| Pubmed | 2.40e-06 | 4 | 295 | 3 | 34838521 | ||
| Pubmed | 2.40e-06 | 4 | 295 | 3 | 1310259 | ||
| Pubmed | 2.40e-06 | 4 | 295 | 3 | 26355550 | ||
| Pubmed | Retinoids activate RXR/CAR-mediated pathway and induce CYP3A. | 2.40e-06 | 4 | 295 | 3 | 19686701 | |
| Pubmed | CYLD USP34 TDRD15 GAPVD1 ATP7A NOL6 KIAA0319L EFTUD2 MET SEC24D WIZ DLG3 CAMK4 PCDHB2 RICTOR OCRL SLC3A2 ARL2 CTBP1 LRBA ATP1A1 | 3.70e-06 | 777 | 295 | 21 | 35844135 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | NT5C3A SPCS2 MCL1 NCLN DDX1 NUP205 EFTUD2 ABRAXAS2 FOXRED2 TELO2 PRMT5 KLHL13 PYCR1 PISD GMPPA BAG6 ILVBL KPNA2 RANGAP1 CAMK2B CAMK2D POLD2 CAMK2G ABCF2 SLC3A2 MTR CTBP1 ATP1A1 | 3.79e-06 | 1257 | 295 | 28 | 37317656 |
| Pubmed | MYH10 PPM1M ITPR1 ABRAXAS2 PHF2 PTPN11 WIZ PTPRD TELO2 GLYR1 KCNMA1 PYCR1 SLC39A6 PYCR2 KPNA2 ABCC1 PSAT1 RANGAP1 RICTOR SLC3A2 ARL2 MTMR4 MTMR14 CEBPZ TTI1 | 4.05e-06 | 1049 | 295 | 25 | 27880917 | |
| Pubmed | 4.27e-06 | 29 | 295 | 5 | 15071553 | ||
| Pubmed | 4.75e-06 | 14 | 295 | 4 | 10373510 | ||
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | MYH10 ITGAE EVI5 PTPN11 PRMT5 BAG6 TDRD5 COL6A3 FLNC ABCF2 CELSR3 | 5.13e-06 | 231 | 295 | 11 | 36597993 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | GAPVD1 MYH10 PDGFRB NOL6 NCLN DDX1 NUP205 EFTUD2 PHF2 PTPN11 GLYR1 PRMT5 PYCR1 ANP32E PYCR2 BAG6 PLXNA1 KPNA2 PSAT1 RANGAP1 DYNC2H1 CAMK2B POLRMT ABCF2 NUP214 SLC3A2 CEBPZ MTR ATM ATP1A1 | 5.14e-06 | 1425 | 295 | 30 | 30948266 |
| Pubmed | Retinoic acid signaling is necessary for the development of the organ of Corti. | 5.97e-06 | 5 | 295 | 3 | 10452855 | |
| Pubmed | 5.97e-06 | 5 | 295 | 3 | 11160423 | ||
| Pubmed | 5.97e-06 | 5 | 295 | 3 | 19671701 | ||
| Pubmed | Developmental expression of murine retinoid X receptor (RXR) genes. | 5.97e-06 | 5 | 295 | 3 | 8199055 | |
| Pubmed | PTENα Modulates CaMKII Signaling and Controls Contextual Fear Memory and Spatial Learning. | 5.97e-06 | 5 | 295 | 3 | 28636948 | |
| Pubmed | 5.97e-06 | 5 | 295 | 3 | 7476975 | ||
| Pubmed | 6.43e-06 | 15 | 295 | 4 | 9481670 | ||
| Pubmed | The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1. | 6.43e-06 | 15 | 295 | 4 | 14622581 | |
| Pubmed | CYLD USP34 GAPVD1 ABCF3 CYP27B1 SPCS2 C2CD5 ITPR1 GLYR1 PAN2 N4BP2L2 PLEC ZWILCH CAMK2D POLD2 PRAMEF20 OAS1 RICTOR IRGQ KIFC2 SLC6A2 AOPEP VCAN TMEM131 LRRC71 | 7.12e-06 | 1084 | 295 | 25 | 11544199 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | MYH10 SLIT2 GLYR1 ERI3 PYCR1 IGSF9 PYCR2 SHANK1 CAMK2A CAMK2B DHRS4L2 CAMK2G SPECC1 SPTBN4 FAM13A NECAB3 CTBP1 | 7.18e-06 | 560 | 295 | 17 | 21653829 |
| Pubmed | EFCAB5 GAPVD1 SLC35B2 PTPN11 PRMT5 AP5Z1 ANP32E PYCR2 GMPPA KPNA2 ABCC1 PSAT1 RANGAP1 NAGK ABCF2 SLC3A2 SHQ1 TKFC CTBP1 LRBA ATP1A1 ATP1A3 | 7.19e-06 | 878 | 295 | 22 | 37223481 | |
| Pubmed | PTPN11 DLG3 CARNS1 FLNC NAGK CAMK2A CAMK2B CAMK2D CAMK2G IRGQ WDR91 ATP1A1 ATP1A3 | 8.17e-06 | 341 | 295 | 13 | 29791485 | |
| Pubmed | CYLD MAGI1 KCTD9 MYH10 EFTUD2 WIZ PTPRD KCNJ10 KCNMA1 DLG3 SHANK1 STRN3 RANGAP1 CAMK2A CAMK2B CAMK2D CAMK2G HCN3 GRM4 SPTBN4 WDR91 KIAA1217 CTBP1 | 9.61e-06 | 963 | 295 | 23 | 28671696 | |
| Pubmed | A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. | 9.65e-06 | 34 | 295 | 5 | 12577067 | |
| Pubmed | 1.11e-05 | 17 | 295 | 4 | 10668806 | ||
| Pubmed | Spatial distributions of retinoic acid receptor gene transcripts in the prenatal mouse inner ear. | 1.19e-05 | 6 | 295 | 3 | 9548551 | |
| Pubmed | 1.19e-05 | 6 | 295 | 3 | 8801169 | ||
| Pubmed | 1.19e-05 | 6 | 295 | 3 | 8801176 | ||
| Pubmed | 1.19e-05 | 6 | 295 | 3 | 22205725 | ||
| Pubmed | A genetic dissection of the retinoid signalling pathway in the mouse. | 1.19e-05 | 6 | 295 | 3 | 10604193 | |
| Pubmed | 1.19e-05 | 6 | 295 | 3 | 9153406 | ||
| Pubmed | The RXRalpha ligand-dependent activation function 2 (AF-2) is important for mouse development. | 1.19e-05 | 6 | 295 | 3 | 9806918 | |
| Pubmed | 1.19e-05 | 6 | 295 | 3 | 7947324 | ||
| Pubmed | Systematic immunolocalization of retinoid receptors in developing and adult mouse eyes. | 1.19e-05 | 6 | 295 | 3 | 11328745 | |
| Pubmed | 1.19e-05 | 6 | 295 | 3 | 16120608 | ||
| Pubmed | Functional specificity of the two retinoic acid receptor RAR and RXR families in myogenesis. | 1.19e-05 | 6 | 295 | 3 | 9464546 | |
| Pubmed | 1.19e-05 | 6 | 295 | 3 | 16428452 | ||
| Pubmed | A β(IV)-spectrin/CaMKII signaling complex is essential for membrane excitability in mice. | 1.19e-05 | 6 | 295 | 3 | 20877009 | |
| Pubmed | Inflammatory chemokine release of astrocytes in vitro is reduced by all-trans retinoic acid. | 1.19e-05 | 6 | 295 | 3 | 20557428 | |
| Pubmed | Requirement of Ca2+ and CaMKII for Stat1 Ser-727 phosphorylation in response to IFN-gamma. | 1.19e-05 | 6 | 295 | 3 | 11972023 | |
| Interaction | LMBR1L interactions | KCTD9 GAPVD1 FAM234A GHDC NT5C3A SARM1 SPCS2 SLC35B2 NCLN RNF43 DDX1 NUP205 SLIT2 FOXRED2 SLC12A9 TELO2 BAG6 ILVBL KPNA2 SEL1L ABCC1 RANGAP1 INTS7 DYNC2H1 CAMK2D ABCF2 NUP214 OCRL URGCP SLC3A2 SLC4A2 IFRD1 CEBPZ MTR ATP1A1 ATP1A3 | 1.04e-07 | 946 | 290 | 36 | int:LMBR1L |
| Interaction | NXT2 interactions | 5.28e-06 | 48 | 290 | 7 | int:NXT2 | |
| Interaction | CAMK2N1 interactions | 8.24e-06 | 10 | 290 | 4 | int:CAMK2N1 | |
| Interaction | PCDHGB1 interactions | 1.49e-05 | 77 | 290 | 8 | int:PCDHGB1 | |
| Interaction | C5AR2 interactions | 1.64e-05 | 78 | 290 | 8 | int:C5AR2 | |
| GeneFamily | ATPase Na+/K+ transporting subunits | 4.52e-05 | 7 | 200 | 3 | 1208 | |
| GeneFamily | EF-hand domain containing|Plakins | 7.17e-05 | 8 | 200 | 3 | 939 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 7.77e-05 | 161 | 200 | 9 | 593 | |
| GeneFamily | Collagens | 1.49e-04 | 46 | 200 | 5 | 490 | |
| GeneFamily | ATP binding cassette subfamily F | 3.63e-04 | 3 | 200 | 2 | 810 | |
| GeneFamily | Cytochrome P450 family 11 | 3.63e-04 | 3 | 200 | 2 | 1007 | |
| GeneFamily | TTT complex | 3.63e-04 | 3 | 200 | 2 | 1320 | |
| GeneFamily | Clustered protocadherins | 7.08e-04 | 64 | 200 | 5 | 20 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 7.20e-04 | 4 | 200 | 2 | 1252 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 9.63e-04 | 18 | 200 | 3 | 1160 | |
| GeneFamily | PDZ domain containing | 1.53e-03 | 152 | 200 | 7 | 1220 | |
| GeneFamily | Class II Cys-based phosphatases|Acid phosphatases | 2.47e-03 | 7 | 200 | 2 | 1071 | |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_DN | CYP27B1 NOL6 NCLN EVI5 SDC4 COL6A3 ZWILCH CAMK2D POLD2 LAG3 ABCF2 SLC3A2 | 2.78e-06 | 198 | 295 | 12 | M7401 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 ABCA12 ADGRV1 PTPRD TRHDE CACNA1F FRAS1 COL11A1 COL12A1 TENM4 HMCN1 TENM1 ATP1A4 HYDIN | 2.59e-11 | 184 | 295 | 14 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 ABCA12 ADGRV1 PTPRD TRHDE CACNA1F FRAS1 COL11A1 COL12A1 TENM4 HMCN1 TENM1 ATP1A4 HYDIN | 2.59e-11 | 184 | 295 | 14 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 ABCA12 ADGRV1 PTPRD TRHDE CACNA1F FRAS1 COL11A1 COL12A1 TENM4 HMCN1 TENM1 ATP1A4 HYDIN | 2.59e-11 | 184 | 295 | 14 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | CYP1B1 PDGFRB ITPR1 SLIT2 SEC24D COL5A1 COL6A3 ITGA11 COL12A1 DYNC2H1 CDH19 SPECC1 TENM4 VCAN | 4.59e-11 | 192 | 295 | 14 | 60b1312e84f6d6448365a952469c506c00b5fe93 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA12 COL6A5 ADGRV1 KCNMA1 PDZRN4 TRHDE FRAS1 COL11A1 COL12A1 CRYM HMCN1 ASTN1 HYDIN | 5.90e-11 | 160 | 295 | 13 | c381ec6be8cf887861cc18f831a20db42f953fe1 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA12 COL6A5 ADGRV1 KCNMA1 PDZRN4 TRHDE FRAS1 COL11A1 COL12A1 CRYM HMCN1 ASTN1 HYDIN | 5.90e-11 | 160 | 295 | 13 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CYP1B1 PDGFRB SERPINF1 SLIT2 C1R PDZRN4 COL5A1 COL6A3 ITGA11 COL12A1 SYNE3 VCAN TENM1 | 9.41e-10 | 200 | 295 | 13 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | CYP1B1 PDGFRB SERPINF1 C1R COL5A1 COL6A3 ITGA11 COL11A1 COL12A1 VCAN HSPB6 ATP1A4 | 6.92e-09 | 193 | 295 | 12 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | CYP1B1 PDGFRB SERPINF1 C1R COL5A1 COL6A3 ITGA11 COL11A1 COL12A1 VCAN HSPB6 ATP1A4 | 6.92e-09 | 193 | 295 | 12 | e2ee077fd381bd906e6b4329f22e7d106e422a7f |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | CYP1B1 PDGFRB SERPINF1 PYCR1 C1R COL5A1 COL6A3 ITGA11 COL11A1 COL12A1 VCAN HSPB6 | 7.33e-09 | 194 | 295 | 12 | d3db241ea316bbcde6d16618193b474591ad5ce4 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | CYP1B1 PDGFRB SERPINF1 PYCR1 C1R COL5A1 COL6A3 ITGA11 COL11A1 COL12A1 VCAN HSPB6 | 7.33e-09 | 194 | 295 | 12 | 29f83cdd63314fff41258937d70b881a5503bfcc |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | CYP1B1 PDGFRB SERPINF1 C1R COL5A1 COL6A3 ITGA11 COL11A1 COL12A1 VCAN HSPB6 ATP1A4 | 8.71e-09 | 197 | 295 | 12 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | PDGFRB SERPINF1 SLIT2 PTPRD COL5A1 COL6A3 COL11A1 COL12A1 TENM4 VCAN HSPB6 DISP1 | 9.22e-09 | 198 | 295 | 12 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CYP1B1 PDGFRB PTPRD C1R PDZRN4 COL5A1 COL6A3 ITGA11 COL11A1 COL12A1 ITGA10 VCAN | 1.03e-08 | 200 | 295 | 12 | a4ec0e80f5422b91b85264a9bb74568dd577e285 |
| ToppCell | Biopsy_IPF-Mesenchymal-HAS1_High_Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | CYP1B1 PDGFRB COL5A1 COL6A3 FLNC ITGA11 COL12A1 HMCN1 KIAA1217 HSPB6 SNTG1 PCDHGC3 | 1.03e-08 | 200 | 295 | 12 | d02e256b5d65a5c982ba5696bc7e077281ca3e24 |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | MYH10 PDGFRB SERPINF1 COL6A5 SLIT2 PTPRD C1R COL5A1 COL6A3 FRAS1 HMCN1 HSPB6 | 1.03e-08 | 200 | 295 | 12 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ADGRV1 ITGB6 RNF43 MET SEC24D C5 SDC4 ARHGEF28 TENM4 FAM13A ATP1A1 | 3.34e-08 | 179 | 295 | 11 | fd2cbee532e7b44113410dca82aec7db1a7fb69f |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 ITGB6 ADCY6 SLIT2 KCNJ10 RPS6KA6 SDC4 PDZRN4 KRT7 LRBA ATP1A1 | 6.49e-08 | 191 | 295 | 11 | 297bc79adc5fef211497819b4861b52cd26ac754 |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 ITGB6 ADCY6 SLIT2 KCNJ10 RPS6KA6 SDC4 PDZRN4 KRT7 LRBA ATP1A1 | 6.49e-08 | 191 | 295 | 11 | e1ec165ba6578cefd88895e7e183190e79f733a4 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | MAGI1 ITGB6 MAP3K1 MET KLHL13 TRHDE KRT7 ARHGEF28 AOPEP ATP1A1 HYDIN | 7.61e-08 | 194 | 295 | 11 | e577d9e88390b36b5a09b97fe1026089892275a3 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | CYP1B1 PDGFRB SERPINF1 C1R COL5A1 COL6A3 ITGA11 COL11A1 COL12A1 VCAN HSPB6 | 7.61e-08 | 194 | 295 | 11 | 02b8102be9414d6964cd71019613edff6d88b893 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDGFRB COL6A5 SLIT2 TRHDE COL5A1 COL6A3 ARL2 TENM4 HMCN1 VCAN TENM1 | 8.89e-08 | 197 | 295 | 11 | 44673c38384453207871d3fd8e8ba9093cc06bc5 |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | MYH10 PDGFRB SLIT2 PTPRD C1R COL5A1 COL6A3 COL12A1 TENM4 HMCN1 VCAN | 8.89e-08 | 197 | 295 | 11 | f1c8936986123a3151140c374fcd62d6705c530b |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | MATN4 ADGRV1 RNF43 MET SCN1A C5 SDC4 CACNA1F ARHGEF28 FAM13A ATP1A1 | 8.89e-08 | 197 | 295 | 11 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | CYP1B1 MYH10 PDGFRB SERPINF1 COL6A5 SLIT2 PTPRD COL5A1 COL6A3 DYNC2H1 VCAN | 9.85e-08 | 199 | 295 | 11 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | MYH10 PDGFRB SERPINF1 COL6A5 SLIT2 PTPRD TRHDE COL5A1 COL6A3 DYNC2H1 VCAN | 1.04e-07 | 200 | 295 | 11 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | CYP1B1 MYH10 PDGFRB SERPINF1 COL6A5 SLIT2 PTPRD COL5A1 COL6A3 DYNC2H1 VCAN | 1.04e-07 | 200 | 295 | 11 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDGFRB COL6A5 SLIT2 KLHL13 C1R TRHDE COL5A1 COL6A3 HMCN1 VCAN TENM1 | 1.04e-07 | 200 | 295 | 11 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | PDGFRB SERPINF1 SLIT2 C1R PDZRN4 COL5A1 COL6A3 ITGA11 COL12A1 VCAN HSPB6 | 1.04e-07 | 200 | 295 | 11 | 6f7f015b5fa1f52374f2c7d9ba339012395eda5f |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | PDGFRB SERPINF1 SLIT2 C1R PDZRN4 COL5A1 COL6A3 ITGA11 COL12A1 VCAN HSPB6 | 1.04e-07 | 200 | 295 | 11 | 3a164e3971bcd62b148b813171c103adb81f972e |
| ToppCell | (1)_Control_(PBS)-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | PLPP5 ACP5 SERPINF1 TMTC2 SEC24D PYCR1 SDC4 COL5A1 ITGA10 IFRD1 | 1.21e-07 | 160 | 295 | 10 | ab769516f9f7798d1390ef215caf22a2d3d53e63 |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADGRV1 IL4I1 SDC4 PDZRN4 TRHDE FRAS1 COL11A1 COL12A1 HMCN1 HYDIN | 2.78e-07 | 175 | 295 | 10 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | CYP1B1 PDGFRB SERPINF1 C1R COL6A3 COL12A1 HHLA1 ARL2 VCAN HSPB6 | 2.93e-07 | 176 | 295 | 10 | fcf324e6402819683f95e0dd94bf1f777c7f4c76 |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Htr2c_(Lateral_habenula)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.17e-07 | 99 | 295 | 8 | 3dd31ed90bd1655cad954045afaef50de889008b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | PDGFRB COL6A5 C1R COL5A1 COL6A3 ITGA11 COL11A1 COL12A1 VCAN HSPB6 | 3.80e-07 | 181 | 295 | 10 | c62b0a2422377ffadaab63edd538e87a06fa5017 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | PDGFRB COL6A5 C1R COL5A1 COL6A3 ITGA11 COL11A1 COL12A1 VCAN HSPB6 | 3.80e-07 | 181 | 295 | 10 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | PDGFRB SERPINF1 SLIT2 C1R CNGA3 COL6A3 COL12A1 HMCN1 VCAN HSPB6 | 4.00e-07 | 182 | 295 | 10 | 3dfa9187e9d2bab1d199079d29209c4648220ada |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CYP1B1 PDGFRB SERPINF1 LRRC4 SCN1A COL5A1 COL6A3 ITGA11 COL11A1 HMCN1 | 4.65e-07 | 185 | 295 | 10 | 785c55d39909fac74415f24427979691e7e694e6 |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CYP1B1 PDGFRB SERPINF1 LRRC4 SCN1A COL5A1 COL6A3 ITGA11 COL11A1 HMCN1 | 4.65e-07 | 185 | 295 | 10 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | MYH10 SLIT2 PDZRN4 COL6A3 COL11A1 COL12A1 AOPEP VCAN TMOD1 CDH6 | 5.13e-07 | 187 | 295 | 10 | 464a0c3b92b778911b5f9cd73642e09e3472063a |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | CYP1B1 SERPINF1 C1R PDZRN4 COL5A1 COL6A3 ITGA11 COL12A1 SYNE3 KIAA1217 | 5.38e-07 | 188 | 295 | 10 | ce85a56ac27a6432421dde93a1bafa8b943244b9 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CYP1B1 MYH10 PDGFRB COL6A5 SLIT2 PTPRD C1R COL6A3 CAMK2D VCAN | 5.93e-07 | 190 | 295 | 10 | 45df8fee00f8949937863159d7aa042e72748d9b |
| ToppCell | (0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 6.19e-07 | 147 | 295 | 9 | 87c24843cb0e87ad42e725d08423131a5d2d25a3 | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | MYH10 SERPINF1 SLIT2 PTPRD C1R COL5A1 COL6A3 HMCN1 HSPB6 TENM1 | 6.22e-07 | 191 | 295 | 10 | f12959eebb4167e1aa03de05d7711a702c58b3c9 |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | MYH10 SERPINF1 SLIT2 PTPRD C1R COL5A1 COL6A3 HMCN1 HSPB6 TENM1 | 6.22e-07 | 191 | 295 | 10 | 387296b5377ef6839f0812e5b3529a10b5f7d530 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 6.85e-07 | 193 | 295 | 10 | ca7c0a4ceb05bced90f6cdc53d278e547fb241e9 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | MAGI1 PDGFRB SLIT2 C1R PDZRN4 COL6A3 FRAS1 COL12A1 TENM4 HMCN1 | 6.85e-07 | 193 | 295 | 10 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | MAGI1 PDGFRB SLIT2 C1R PDZRN4 COL6A3 FRAS1 COL12A1 TENM4 HMCN1 | 6.85e-07 | 193 | 295 | 10 | e4ea7ce011a80b81b841c907719aa532bed39d2e |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | MAGI1 PDGFRB SLIT2 C1R PDZRN4 COL6A3 FRAS1 COL12A1 TENM4 HMCN1 | 6.85e-07 | 193 | 295 | 10 | cf2461af78f65616ce40d552ee9452295e3895ed |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | PDGFRB C1R COL5A1 COL6A3 ITGA11 COL11A1 COL12A1 TENM4 HMCN1 CDH6 | 6.85e-07 | 193 | 295 | 10 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | CYP1B1 SLIT2 C1R COL5A1 COL6A3 ITGA11 COL12A1 CDH19 TENM4 VCAN | 7.18e-07 | 194 | 295 | 10 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MYH10 PDGFRB SERPINF1 COL6A5 SLIT2 PTPRD C1R TRHDE COL5A1 COL6A3 | 7.18e-07 | 194 | 295 | 10 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MYH10 SERPINF1 COL6A5 SLIT2 PTPRD C1R TRHDE COL5A1 COL6A3 CAMK2D | 7.18e-07 | 194 | 295 | 10 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | MYH10 PDGFRB SLIT2 COL5A1 COL6A3 ITGA11 COL11A1 TENM4 HMCN1 VCAN | 7.18e-07 | 194 | 295 | 10 | 03a269f75a481ea54aea8e6444605db8d6df493d |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYH10 SERPINF1 SEC24D PYCR1 COL5A1 COL6A3 ITGA11 COL11A1 COL12A1 VCAN | 7.52e-07 | 195 | 295 | 10 | 18b01ab63ee1deae3cf29669d66fff9ca4efc5c4 |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | MYH10 PDGFRB SERPINF1 COL6A5 SLIT2 C1R COL6A3 VCAN HSPB6 CDH6 | 7.52e-07 | 195 | 295 | 10 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | SERPINF1 SLIT2 C1R COL5A1 COL6A3 COL12A1 DYNC2H1 CDH19 TENM4 VCAN | 7.52e-07 | 195 | 295 | 10 | f423baa36ac7cdc383c033e35a7d17e6bf913323 |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | MYH10 PDGFRB SERPINF1 COL6A5 SLIT2 C1R COL6A3 VCAN HSPB6 CDH6 | 7.52e-07 | 195 | 295 | 10 | c269c0d894a0f55da6495b59d4b9abb9f68df684 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | MYH10 PDGFRB SERPINF1 COL6A5 SLIT2 C1R COL5A1 COL6A3 HMCN1 HSPB6 | 7.88e-07 | 196 | 295 | 10 | 42e9828222a9663525d571633e8a454c30bfa7f8 |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | CYP1B1 PDGFRB SLIT2 COL5A1 COL6A3 ITGA11 COL11A1 COL12A1 DYNC2H1 ITGA10 | 8.25e-07 | 197 | 295 | 10 | c165c6fd12dc649b39e920d8528e2eb65c61956b |
| ToppCell | tumor_Lung-Fibroblasts-Myofibroblasts|tumor_Lung / Location, Cell class and cell subclass | PDGFRB SERPINF1 C1R COL5A1 COL6A3 ITGA11 COL11A1 COL12A1 AOPEP VCAN | 8.64e-07 | 198 | 295 | 10 | 31f9181dab689aabe9c6182c2ef7de65ba3f0ff6 |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 8.64e-07 | 198 | 295 | 10 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ADGRV1 RNF43 MET SEC24D C5 SDC4 CACNA1F ARHGEF28 FAM13A ATP1A1 | 8.64e-07 | 198 | 295 | 10 | 285f729140b1df029c24f6ca1d2438470ac51794 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | CYP1B1 PDGFRB SLIT2 C1R PDZRN4 COL6A3 COL11A1 COL12A1 TENM4 VCAN | 9.05e-07 | 199 | 295 | 10 | 9b2262edbdec89166d895ab97527e0ee5f9b6010 |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | MYH10 PDGFRB SERPINF1 COL6A5 SLIT2 C1R COL5A1 HMCN1 HSPB6 TENM1 | 9.05e-07 | 199 | 295 | 10 | e1f1950d6f840485e263b83dc81b98910be3ae7a |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MYH10 PDGFRB SERPINF1 COL6A5 SLIT2 PTPRD COL5A1 COL6A3 DYNC2H1 VCAN | 9.05e-07 | 199 | 295 | 10 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | CYP1B1 MYH10 PDGFRB SERPINF1 COL6A5 SLIT2 PTPRD COL5A1 COL6A3 VCAN | 9.05e-07 | 199 | 295 | 10 | e1849505b92820a219c5a2c35492bdd55579fb48 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | CYP1B1 PDGFRB SLIT2 C1R PDZRN4 COL6A3 COL11A1 COL12A1 TENM4 VCAN | 9.05e-07 | 199 | 295 | 10 | 251b3643dcd8f4645b17101bd716e66f12a20e88 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | CYP1B1 PDGFRB SLIT2 C1R PDZRN4 COL6A3 COL11A1 COL12A1 TENM4 VCAN | 9.05e-07 | 199 | 295 | 10 | 117f4f43b6c06dda553799b1063e827bce697370 |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | C1R PDZRN4 SHANK1 COL6A3 ITGA11 COL11A1 DYNC2H1 ITGA10 TENM4 VCAN | 9.05e-07 | 199 | 295 | 10 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | MYH10 PDGFRB SERPINF1 COL6A5 SLIT2 PTPRD TRHDE COL5A1 COL6A3 VCAN | 9.47e-07 | 200 | 295 | 10 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | MYH10 PDGFRB COL6A5 SLIT2 PTPRD C1R COL6A3 FRAS1 HMCN1 PCDHGC3 | 9.47e-07 | 200 | 295 | 10 | aa1a35dcca3b799241eef4237f6eb94660e019f0 |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | CYP1B1 PDGFRB SERPINF1 PYCR1 C1R COL5A1 COL6A3 COL12A1 HMCN1 VCAN | 9.47e-07 | 200 | 295 | 10 | 4dbe21cb63569f28c7017cda065ea5ee00d7254e |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | MYH10 PDGFRB COL6A5 SLIT2 PTPRD C1R COL6A3 FRAS1 HMCN1 PCDHGC3 | 9.47e-07 | 200 | 295 | 10 | a510deaada669e690329183e18df02870bd204b3 |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | CYP1B1 PDGFRB SERPINF1 PYCR1 C1R COL5A1 COL6A3 COL12A1 HMCN1 VCAN | 9.47e-07 | 200 | 295 | 10 | 8256511b099c3eab8e33194f90c9ff354e7cfe8e |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDGFRB SLIT2 C1R TRHDE COL5A1 COL6A3 COL12A1 HMCN1 VCAN TENM1 | 9.47e-07 | 200 | 295 | 10 | b4ccffdd79526c85e5273d27b668dbddcddba1ee |
| ToppCell | Skin-Fibroblasts|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | PDGFRB SERPINF1 SLIT2 C1R COL5A1 COL6A3 ITGA11 COL12A1 VCAN HSPB6 | 9.47e-07 | 200 | 295 | 10 | f777eadf571a1a6d246da87346a9cb9d511c2e81 |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | MYH10 PDGFRB SERPINF1 SLIT2 PYCR1 C1R COL5A1 COL6A3 HMCN1 HSPB6 | 9.47e-07 | 200 | 295 | 10 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | MYH10 PDGFRB COL6A5 SLIT2 PTPRD C1R COL5A1 COL6A3 HMCN1 HSPB6 | 9.47e-07 | 200 | 295 | 10 | c2c6f687c49ba790174b27c7b8b084af30b34c86 |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | MYH10 PDGFRB SERPINF1 SLIT2 PTPRD C1R COL5A1 COL6A3 HMCN1 HSPB6 | 9.47e-07 | 200 | 295 | 10 | e504570fd7eec1524c401b1cfa9d10822d80d994 |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | CYP1B1 MYH10 PDGFRB SERPINF1 C1R COL5A1 COL6A3 COL12A1 HMCN1 VCAN | 9.47e-07 | 200 | 295 | 10 | e663995fc44c340d878d66b278b7b5c2ff784301 |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | PDGFRB SERPINF1 SLIT2 C1R PDZRN4 COL5A1 COL6A3 COL12A1 VCAN HSPB6 | 9.47e-07 | 200 | 295 | 10 | a637281d91e95734ee4f8510b3780e0272b16fda |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_SERPINF1-high|Airway / Age, Tissue, Lineage and Cell class | MYH10 PDGFRB SERPINF1 PTPRD C1R COL5A1 COL6A3 CRYM VCAN FAM43A | 9.47e-07 | 200 | 295 | 10 | 14ae55660f7412518dcb5cb982f6fe9f23553cfb |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-4|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | CYP1B1 PDGFRB SERPINF1 PYCR1 C1R COL5A1 COL6A3 COL12A1 HMCN1 VCAN | 9.47e-07 | 200 | 295 | 10 | bde938e5a18844fb8cc1d1be5a086809f7e2b97d |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | CYP1B1 MYH10 PDGFRB SERPINF1 C1R COL5A1 COL6A3 COL12A1 HMCN1 VCAN | 9.47e-07 | 200 | 295 | 10 | 2cb8a39a12522a9643c6244d5e94cb4559868bb9 |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-3|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | CYP1B1 MYH10 PDGFRB SERPINF1 C1R COL5A1 COL6A3 COL12A1 HMCN1 VCAN | 9.47e-07 | 200 | 295 | 10 | 8cc5057b0e5ae9b72ea40d2ffbc52b79bf87ccef |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | MYH10 PDGFRB SERPINF1 COL6A5 SLIT2 PTPRD TRHDE COL5A1 COL6A3 VCAN | 9.47e-07 | 200 | 295 | 10 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | MYH10 PDGFRB SERPINF1 COL6A5 SLIT2 PTPRD TRHDE COL5A1 COL6A3 VCAN | 9.47e-07 | 200 | 295 | 10 | bd8cf33502adea320e91ca2af14e1911d88ad374 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | MYH10 PDGFRB COL6A5 SLIT2 PTPRD C1R COL6A3 FRAS1 HMCN1 PCDHGC3 | 9.47e-07 | 200 | 295 | 10 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-06 | 176 | 295 | 9 | c6484334187f64cd00cd35e77d8ae436556b4260 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.90e-06 | 177 | 295 | 9 | d05497d2c80a66ec6a4e1733fea3a5534877a6a7 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.90e-06 | 177 | 295 | 9 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-06 | 179 | 295 | 9 | 68ccfe66474d049a926afc21bffa231446becc69 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_postreplicative-neuro_migrating_neuronal_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.18e-06 | 179 | 295 | 9 | df6d2cdc4e204ce1a4628dc71dfbc5e6c6309b2a | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.33e-06 | 180 | 295 | 9 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | ABCA4 MET SLC22A10 PDZRN4 TRHDE COL5A1 COL11A1 FRMPD2 LINGO2 | 3.33e-06 | 180 | 295 | 9 | 2ae39e26a8e7d5d4d3e1e71609a8ec36fd9855aa |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.33e-06 | 180 | 295 | 9 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.48e-06 | 181 | 295 | 9 | 6e8c5460021d3999daec58e3d6661a6fa998fd16 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-06 | 182 | 295 | 9 | f4b74c2756989812abe4e7055ec8918f69d56025 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | CYP1B1 PDGFRB COL5A1 COL6A3 ITGA11 COL12A1 CDH19 SPECC1 TENM4 | 3.64e-06 | 182 | 295 | 9 | fbd5e332df73bf7141c822fa67b76367dc962017 |
| Drug | 2,4,5,2',5'-pentachlorobiphenyl | MAGI1 CYP1B1 CYP11B1 CYP11B2 CYP27B1 SPCS2 RNF43 RYR1 MAP3K1 ITPR1 NUP205 CENPP SCN1A KCNMA1 IGSF9 GMPPA KPNA2 NLRP5 SHANK1 CACNA1F COL6A3 ZWILCH COL11A1 COL12A1 INTS7 CAMK4 CAMK2A CAMK2B HCN3 GRIN2C PRX SLC6A2 SPC24 ELMO3 CELSR3 MTMR14 TMEM132E HELZ2 SNTG1 ATM LRBA URAD PPTC7 | 2.49e-07 | 1441 | 294 | 43 | ctd:C009828 |
| Drug | 2,4,4'-trichlorobiphenyl | MAGI1 CYP1B1 CYP11B1 CYP27B1 SPCS2 RNF43 MAP3K1 ITPR1 NUP205 CENPP SCN1A KCNMA1 IGSF9 GMPPA KPNA2 NLRP5 SHANK1 CACNA1F COL6A3 ZWILCH COL11A1 COL12A1 INTS7 CAMK4 CAMK2A CAMK2B HCN3 GRIN2C PRX SLC6A2 SPC24 ELMO3 CELSR3 MTMR14 TMEM132E HELZ2 SNTG1 ATM LRBA URAD PPTC7 | 9.72e-07 | 1411 | 294 | 41 | ctd:C081766 |
| Drug | potassium | CYP11B1 CYP11B2 NT5C3A TCIRG1 ADCY6 RYR1 ITPR1 SLC12A9 GLYR1 KCNJ10 KCNMA1 RPS6KA6 DLG3 ATP8B3 CACNA1F FLT4 CAMK2B CAMK2D POLD2 HCN3 GRIN2C GRM4 SLC3A2 CACNA2D4 CRYM MTR PCSK7 LRBA ATP1A1 ATP1A3 ATP12A ATP1A4 TPH1 | 9.85e-07 | 1008 | 294 | 33 | CID000000813 |
| Drug | Bexarotene | 2.13e-06 | 3 | 294 | 3 | DB00307 | |
| Drug | 2-hydroxyphytanic acid | 2.13e-06 | 3 | 294 | 3 | ctd:C002585 | |
| Drug | AC1O5SBP | 2.13e-06 | 3 | 294 | 3 | CID006439746 | |
| Drug | (2s,5s)-5-Carboxymethylproline | PDGFRB MC1R SSR2 ITGAE ITGB6 PRMT5 PLXNA1 COL5A1 COL6A3 ITGA11 COL11A1 COL12A1 CAMK4 ITGA10 PRKAG3 TMEM131 | 3.66e-06 | 314 | 294 | 16 | CID000447989 |
| Drug | fluo-3 | RYR1 ITPR1 PTPRD KCNMA1 ABCC1 CAMK2B CAMK2D ABCB5 GRIN2C CACNA2D4 | 4.27e-06 | 122 | 294 | 10 | CID000104978 |
| Drug | AGN 191701 | 8.37e-06 | 11 | 294 | 4 | CID006438168 | |
| Drug | AGN 190727 | 8.44e-06 | 4 | 294 | 3 | CID006439768 | |
| Drug | Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; MCF7; HT_HG-U133A | KIAA0319L ITPR1 MET WIZ GLYR1 PLEC CAMK2B CAMK2G ABCF2 TBC1D8 TMOD1 ATM | 8.93e-06 | 194 | 294 | 12 | 2221_DN |
| Drug | Isradipine [75695-93-1]; Down 200; 10.8uM; PC3; HT_HG-U133A | CYP1B1 GAK VWA8 EVPL MET SLC12A9 ERI3 PAN2 C5 OCRL IRGQ MEAK7 | 8.93e-06 | 194 | 294 | 12 | 6347_DN |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Down 200; 12.2uM; MCF7; HT_HG-U133A | CYLD ITPR1 EVI5 SLIT2 MET AP5Z1 COL5A1 ITGA10 OAS3 VPS13D CELSR3 CDH6 | 9.41e-06 | 195 | 294 | 12 | 4980_DN |
| Drug | Cinnarizine [298-57-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A | ABCA12 DELE1 ADCY6 GLYR1 DLG3 ABCC1 INTS7 DYNC2H1 OPA3 WDR91 VPS13D ATM | 1.04e-05 | 197 | 294 | 12 | 7174_UP |
| Drug | (S)-(-)-Atenolol [93379-54-5]; Down 200; 15uM; PC3; HT_HG-U133A | IL15 SARM1 MCL1 ZZEF1 EVI5 SEC24D FOXRED2 ALDH6A1 NUP214 GRM4 VCAN HSPB6 | 1.10e-05 | 198 | 294 | 12 | 6725_DN |
| Drug | Avermectin B1 [71751-41-2]; Down 200; 4.8uM; PC3; HT_HG-U133A | USP34 CYP27B1 EVPL SLC12A9 DLG3 PISD ABCC1 RANGAP1 OAS3 IRGQ VPS13D VCAN | 1.10e-05 | 198 | 294 | 12 | 5864_DN |
| Drug | Ranitidine hydrochloride [66357-59-3]; Up 200; 11.4uM; MCF7; HT_HG-U133A | CYLD SARM1 ITPR1 AP5Z1 KCNMA1 RPS6KA6 PLXNA1 SHANK1 COL6A3 CAMK2G SNTG1 TMOD1 | 1.10e-05 | 198 | 294 | 12 | 5425_UP |
| Drug | AC1L1GTT | CYP11B2 RYR1 ITPR1 CAMK4 CAMK2A CAMK2B CAMK2D CAMK2G NUP214 GRIN2C SLC6A2 CACNA2D4 LRBA | 1.15e-05 | 233 | 294 | 13 | CID000003837 |
| Drug | 5-aza-2′-deoxycytidine; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | VWA8 SERPINF1 KIAA0319L RNF43 WIZ TIMM17A KRT7 FLT4 DYNC2H1 ABCF2 OPA3 EHHADH | 1.15e-05 | 199 | 294 | 12 | 920_DN |
| Drug | HF-2035 | 1.49e-05 | 25 | 294 | 5 | CID006439511 | |
| Drug | 7-methoxycitronellic acid | 2.09e-05 | 5 | 294 | 3 | CID000171516 | |
| Drug | 7-methoxycitronellal | 2.09e-05 | 5 | 294 | 3 | CID000019223 | |
| Drug | 13,14-dihydroretinol | 2.09e-05 | 5 | 294 | 3 | CID000446798 | |
| Drug | nifedipine | CYP1B1 MYH10 SLC39A1 CYP11B1 CYP11B2 CYP27B1 RYR1 ITPR1 NOD2 KCNMA1 COL5A1 CACNA1F ABCB5 GRIN2C GRM4 CACNA2D4 LRBA | 3.15e-05 | 415 | 294 | 17 | CID000004485 |
| Drug | SR-12813 | 3.20e-05 | 29 | 294 | 5 | CID000446313 | |
| Drug | nafenopin | 3.66e-05 | 71 | 294 | 7 | CID000019592 | |
| Drug | oxypertine | 3.86e-05 | 49 | 294 | 6 | CID000004640 | |
| Drug | Alitretinoin | 4.14e-05 | 6 | 294 | 3 | DB00523 | |
| Drug | Adapalene | 4.14e-05 | 6 | 294 | 3 | DB00210 | |
| Drug | Etretinate | 4.14e-05 | 6 | 294 | 3 | DB00926 | |
| Drug | triphenyltin hydroxide | 4.14e-05 | 6 | 294 | 3 | ctd:C007567 | |
| Drug | Methoprene | 4.14e-05 | 6 | 294 | 3 | ctd:D008726 | |
| Drug | Carbarsone [121-59-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A | ZZEF1 MAP3K1 ITPR1 MET PTPN11 GLYR1 ABCC1 DYNC2H1 OCRL NECAB3 ATM | 4.28e-05 | 192 | 294 | 11 | 4110_DN |
| Drug | Alsterpaullone; Up 200; 10uM; MCF7; HT_HG-U133A | SERPINF1 SARM1 ADCY6 WIZ KCNMA1 COL5A1 KRT7 ARHGEF28 CAMK2B CAMK2G ABCF2 | 4.70e-05 | 194 | 294 | 11 | 7051_UP |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; PC3; HG-U133A | 4.70e-05 | 194 | 294 | 11 | 433_DN | |
| Drug | Indoprofen [31842-01-0]; Down 200; 14.2uM; PC3; HT_HG-U133A | CYP1B1 KIAA0319L ZZEF1 XAB2 EVI5 KCNMA1 ALDH6A1 ABCF2 GRM4 VCAN HSPB6 | 4.70e-05 | 194 | 294 | 11 | 4249_DN |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; MCF7; HT_HG-U133A | USP34 KIAA0319L ITPR1 WIZ AP5Z1 KCNMA1 CAMK4 ITGA10 VPS13D ATM PCDHGC3 | 4.70e-05 | 194 | 294 | 11 | 3938_DN |
| Drug | di-n-pentyl phthalate | 4.87e-05 | 51 | 294 | 6 | ctd:C034171 | |
| Drug | Bumetanide [28395-03-1]; Down 200; 11uM; PC3; HT_HG-U133A | EPPK1 KIAA0319L ADCY6 EVI5 MET COL5A1 OAS3 ABCF2 IRGQ CTBP1 ATM | 4.93e-05 | 195 | 294 | 11 | 5117_DN |
| Drug | Diflorasone Diacetate [33564-31-7]; Down 200; 8uM; MCF7; HT_HG-U133A | CYLD SERPINF1 ZZEF1 WIZ FBXL18 PLXNA1 STRN3 WDR91 NECAB3 TMOD1 CDH6 | 5.16e-05 | 196 | 294 | 11 | 2798_DN |
| Drug | Ethaverine hydrochloride [985-13-7]; Down 200; 9.2uM; PC3; HT_HG-U133A | CYP1B1 SARM1 ZZEF1 FOXRED2 FLT4 CAMK2B PCDHA5 GRM4 CIAO3 HSPB6 ATP1A3 | 5.40e-05 | 197 | 294 | 11 | 6737_DN |
| Drug | Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; PC3; HT_HG-U133A | CYLD KIAA0319L EVI5 RPS6KA6 DLG3 COL5A1 ABCC1 RANGAP1 OPA3 NECAB3 PCSK7 | 5.40e-05 | 197 | 294 | 11 | 7309_DN |
| Drug | Bethanechol chloride [590-63-6]; Down 200; 20.4uM; HL60; HT_HG-U133A | KIAA0319L ABCB4 AP5Z1 PLEC ILVBL STRN3 RANGAP1 OAS1 DHX57 VPS13D CIAO3 | 5.40e-05 | 197 | 294 | 11 | 2975_DN |
| Drug | Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; MCF7; HT_HG-U133A | ABCA12 EVPL NCLN SLIT2 GLYR1 PLXNA1 WDR91 VPS13D ELMO3 ATM CDH6 | 5.66e-05 | 198 | 294 | 11 | 6790_DN |
| Drug | Adrenosterone [382-45-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A | ZZEF1 MAP3K1 ITPR1 AP5Z1 KCNMA1 CAMK4 OAS1 OPA3 VCAN ASTN1 SEZ6L | 5.66e-05 | 198 | 294 | 11 | 5464_UP |
| Drug | 8-azido-ADP | 5.68e-05 | 17 | 294 | 4 | CID000121934 | |
| Drug | clozapine; Up 200; 10uM; MCF7; HG-U133A | AVPR1B WIZ PLEC STRN3 DHX57 OAS3 ABCF2 CUL5 VPS13D CIAO3 SEZ6L | 5.92e-05 | 199 | 294 | 11 | 416_UP |
| Drug | Flucytosine [2022-85-7]; Up 200; 31uM; PC3; HT_HG-U133A | MAGI1 PDGFRB OAS1 PCDHA5 GRM4 VCAN HSPB6 SNTG1 TMOD1 ASTN1 SEZ6L | 5.92e-05 | 199 | 294 | 11 | 6690_UP |
| Drug | bexarotene | CYP1B1 IL15 ITGB6 ADCY6 RXRA RXRB RXRG MAP3K1 ITPR1 KCNMA1 COL12A1 CAMK2G GRIN2C FAM13A EHHADH ATM ATP1A1 | 5.98e-05 | 437 | 294 | 17 | ctd:C095105 |
| Drug | Nadolol [42200-33-9]; Down 200; 13uM; HL60; HT_HG-U133A | KIAA0319L ITGB6 WIZ FBXL18 PLEC DYNC2H1 OAS1 NUP214 VPS13D FAM13A ATM | 6.19e-05 | 200 | 294 | 11 | 3020_DN |
| Drug | AC1MHEDL | 6.73e-05 | 78 | 294 | 7 | CID003002890 | |
| Drug | Acitretin | 7.18e-05 | 7 | 294 | 3 | DB00459 | |
| Drug | AGN 190121 | 7.18e-05 | 7 | 294 | 3 | CID006441236 | |
| Drug | AGN 191659 | 7.18e-05 | 7 | 294 | 3 | CID006366726 | |
| Drug | AC1L3X8G | 7.23e-05 | 18 | 294 | 4 | CID000123753 | |
| Drug | felodipine | CYP1B1 CYP11B1 CYP11B2 CYP27B1 RYR1 ITPR1 NOD2 CACNA1F ABCB5 CACNA2D4 | 7.27e-05 | 169 | 294 | 10 | CID000003333 |
| Drug | verapamil | MYH10 ABCA4 ABCA12 ADCY6 RYR1 ITPR1 ABCB4 KCNJ10 KCNMA1 CACNA1F ABCC1 ABCB5 HCN3 ABCF2 CACNA2D4 PCSK7 ATP1A1 ATP1A3 | 7.58e-05 | 490 | 294 | 18 | CID000002520 |
| Drug | beta-tyrosine | 8.20e-05 | 35 | 294 | 5 | CID000440311 | |
| Drug | MIANS | 1.08e-04 | 37 | 294 | 5 | CID000119532 | |
| Drug | magnesium | NDOR1 PLPP5 NT5C3A ACP5 MC1R TCIRG1 ADGRV1 ADCY6 RYR1 ABCB4 KCNJ10 KCNMA1 PLEC ILVBL ABCC1 ITGA11 RANGAP1 NAGK ABCB5 POLRMT TDG NUP214 GRIN2C MTFMT TKFC ARSA VCAN DNAH17 MTR ACP4 LRBA ATP1A1 ATP1A3 ATP12A | 1.09e-04 | 1325 | 294 | 34 | CID000000888 |
| Drug | TTNN | 1.14e-04 | 8 | 294 | 3 | CID000135754 | |
| Drug | HX 600 | 1.14e-04 | 8 | 294 | 3 | ctd:C104181 | |
| Drug | nicotine glucuronide | 1.14e-04 | 8 | 294 | 3 | CID003035848 | |
| Drug | AC1O5JP6 | 1.14e-04 | 8 | 294 | 3 | CID006435379 | |
| Drug | AC1LD8Z3 | 1.25e-04 | 86 | 294 | 7 | CID000644309 | |
| Drug | N-methyl-DL-aspartic acid | MAGI1 NDOR1 SLC35B2 ADGRV1 RYR1 ITPR1 IGSF9 DLG3 SHANK1 CACNA1F CAMK4 CAMK2A CAMK2B CAMK2D CAMK2G NUP214 GRIN2C GRM4 CACNA2D4 ACP4 LRBA | 1.34e-04 | 655 | 294 | 21 | CID000004376 |
| Drug | p-nitrophenyl-alpha-D-glucopyranoside | 1.34e-04 | 116 | 294 | 8 | CID000065115 | |
| Drug | IAA-94 | 1.35e-04 | 61 | 294 | 6 | CID000003667 | |
| Drug | diheptyl phthalate | 1.37e-04 | 21 | 294 | 4 | ctd:C089799 | |
| Drug | valinomycin | 1.39e-04 | 39 | 294 | 5 | CID000005649 | |
| Drug | mono-(2-ethylhexyl)phthalate | CYP1B1 ABCA4 ABCA12 LRRC4 RXRA RXRB RXRG RYR1 DHRS4 PTPRD SCN1A PDZRN4 COL12A1 MYOM3 SPECC1 PRKAG3 SLC6A2 SPTBN4 PCSK7 ATP1A3 ATP12A | 1.42e-04 | 658 | 294 | 21 | ctd:C016599 |
| Drug | AC1LAKND | 1.48e-04 | 62 | 294 | 6 | CID000470146 | |
| Drug | alpha-ketoisovalerate | 1.56e-04 | 89 | 294 | 7 | CID000000049 | |
| Drug | propidium iodide | 1.57e-04 | 151 | 294 | 9 | CID000004939 | |
| Drug | di-n-hexyl phthalate | 1.66e-04 | 22 | 294 | 4 | ctd:C027387 | |
| Drug | MOSE | 1.66e-04 | 22 | 294 | 4 | CID000134317 | |
| Drug | adapalene | 1.66e-04 | 22 | 294 | 4 | CID000060164 | |
| Drug | cyadox | 1.66e-04 | 2 | 294 | 2 | ctd:C020728 | |
| Drug | 18-hydroxydeoxycorticosterone | 1.66e-04 | 2 | 294 | 2 | ctd:C042509 | |
| Drug | Protriptyline | 1.66e-04 | 2 | 294 | 2 | ctd:D011530 | |
| Drug | MS-209 | 1.69e-04 | 9 | 294 | 3 | CID000213040 | |
| Drug | vitamin D3 analog | 1.78e-04 | 41 | 294 | 5 | CID006438384 | |
| Drug | AG-012559 [369370-06-9]; Down 200; 10uM; PC3; HT_HG-U133A | 1.83e-04 | 189 | 294 | 10 | 6920_DN | |
| Drug | orthovanadate | PDGFRB ACP5 TCIRG1 ADCY6 RYR1 ABCB4 PTPN11 PTPRD ABCC1 ABCB5 KIFC2 DNAH17 ACP4 LRBA ATP1A1 ATP1A3 | 1.87e-04 | 435 | 294 | 16 | CID000061672 |
| Drug | 3-isoreserpine | ABCA4 ABCA12 ADCY6 ABCB4 PRMT5 ABCC1 ABCB5 ABCF2 SLC6A2 TPH1 | 1.91e-04 | 190 | 294 | 10 | CID000005052 |
| Drug | Equilin [474-86-2]; Up 200; 15uM; MCF7; HT_HG-U133A | CYLD KIAA0319L ACOX2 ITPR1 SEC24D ALDH6A1 COL5A1 GRM4 VPS13D PCSK7 | 2.08e-04 | 192 | 294 | 10 | 5620_UP |
| Drug | cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester; Up 200; 100uM; MCF7; HT_HG-U133A_EA | USP34 CYP1B1 ZZEF1 MAP3K1 WIZ AP5Z1 KCNMA1 RPS6KA6 COL5A1 GRM4 | 2.17e-04 | 193 | 294 | 10 | 881_UP |
| Drug | Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; PC3; HT_HG-U133A | CYLD SYNRG SLC39A1 CYP27B1 SARM1 KIAA0319L FBXL18 KCNMA1 SLC4A2 FAM13A | 2.17e-04 | 193 | 294 | 10 | 4285_DN |
| Drug | Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; PC3; HT_HG-U133A | 2.17e-04 | 193 | 294 | 10 | 4226_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA | VWA8 KIAA0319L DELE1 TELO2 COL5A1 SLC4A2 VPS13D CELSR3 ATM LRBA | 2.26e-04 | 194 | 294 | 10 | 1060_UP |
| Drug | Pentoxifylline [6493-05-6]; Down 200; 14.4uM; MCF7; HT_HG-U133A | USP34 KIAA0319L FBXL18 GLYR1 INTS7 PCDHA5 DNAH17 TMOD1 ATM CDH6 | 2.26e-04 | 194 | 294 | 10 | 6021_DN |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.35e-04 | 195 | 294 | 10 | 6927_DN | |
| Drug | Cephalothin sodium salt [58-71-9]; Up 200; 9.6uM; HL60; HT_HG-U133A | NDOR1 ADCY6 MET RPS6KA6 COL5A1 COL11A1 CAMK2B SLC6A2 SNTG1 SEZ6L | 2.35e-04 | 195 | 294 | 10 | 2517_UP |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Down 200; 12.2uM; PC3; HT_HG-U133A | SARM1 KIAA0319L SEC24D FBXL18 TELO2 DLG3 OAS1 OPA3 VPS13D ATM | 2.35e-04 | 195 | 294 | 10 | 6635_DN |
| Drug | Ticlopidine hydrochloride [53885-35-1]; Down 200; 13.4uM; MCF7; HT_HG-U133A | NDOR1 KIAA0319L ITPR1 SLIT2 SEC24D WIZ FBXL18 KCNMA1 CAMK2G VPS13D | 2.35e-04 | 195 | 294 | 10 | 4155_DN |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; MCF7; HT_HG-U133A | KIAA0319L RXRA SEC24D WIZ PLEC RANGAP1 CAMK4 CAMK2G ABCF2 ATM | 2.35e-04 | 195 | 294 | 10 | 2264_DN |
| Drug | 3-(1H-pyrrole-2-carboxylate | ABCA4 RYR1 ITPR1 KCNMA1 CAMK4 CAMK2B CAMK2D NUP214 GRM4 CACNA2D4 LRBA | 2.38e-04 | 233 | 294 | 11 | CID000005114 |
| Drug | HX 630 | 2.39e-04 | 10 | 294 | 3 | ctd:C422175 | |
| Drug | tris(p-aminophenyl)carbonium pamoate | 2.39e-04 | 10 | 294 | 3 | CID000024040 | |
| Drug | diazepinylbenzoic acid | 2.39e-04 | 10 | 294 | 3 | ctd:C438269 | |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 3.13e-07 | 7 | 290 | 4 | DOID:0060178 (implicated_via_orthology) | |
| Disease | heart conduction disease (implicated_via_orthology) | 6.26e-07 | 32 | 290 | 6 | DOID:10273 (implicated_via_orthology) | |
| Disease | nervous system disease (implicated_via_orthology) | 4.25e-06 | 12 | 290 | 4 | DOID:863 (implicated_via_orthology) | |
| Disease | Disorder of eye | CYP1B1 ABCA4 ADGRV1 CNGA3 CACNA1F FRAS1 COL11A1 OPA3 CACNA2D4 VCAN IQCB1 | 8.94e-06 | 212 | 290 | 11 | C0015397 |
| Disease | Conn Syndrome | 1.84e-05 | 6 | 290 | 3 | C1384514 | |
| Disease | Hyperaldosteronism | 1.84e-05 | 6 | 290 | 3 | C0020428 | |
| Disease | Bipolar Disorder | MAGI1 AVPR1B ITPR1 NOD2 DLG3 CAMK2A GRM4 SLC6A2 TENM4 EHHADH MTR ATP1A1 ATP1A3 SEZ6L TPH1 | 8.62e-05 | 477 | 290 | 15 | C0005586 |
| Disease | Glucocorticoid-remediable aldosteronism | 9.63e-05 | 2 | 290 | 2 | C1260386 | |
| Disease | autosomal recessive cutis laxa type IIB (implicated_via_orthology) | 9.63e-05 | 2 | 290 | 2 | DOID:0070137 (implicated_via_orthology) | |
| Disease | adrenal cortical adenoma (is_marker_for) | 9.63e-05 | 2 | 290 | 2 | DOID:0050891 (is_marker_for) | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.14e-04 | 148 | 290 | 8 | C0279702 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.37e-04 | 152 | 290 | 8 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of prostate | CYP1B1 SLC39A1 CYP11B2 SERPINF1 MATN4 SSR2 RNF43 RXRA MAP3K1 ITPR1 MET COL5A1 NAGK SLC4A2 EHHADH TMOD1 ATM | 1.44e-04 | 616 | 290 | 17 | C0376358 |
| Disease | Prostatic Neoplasms | CYP1B1 SLC39A1 CYP11B2 SERPINF1 MATN4 SSR2 RNF43 RXRA MAP3K1 ITPR1 MET COL5A1 NAGK SLC4A2 EHHADH TMOD1 ATM | 1.44e-04 | 616 | 290 | 17 | C0033578 |
| Disease | 3-hydroxyanthranilate 3,4-dioxygenase measurement | 1.46e-04 | 11 | 290 | 3 | EFO_0021862 | |
| Disease | Cone-Rod Dystrophy 2 | 1.79e-04 | 29 | 290 | 4 | C3489532 | |
| Disease | epilepsy (implicated_via_orthology) | 2.21e-04 | 163 | 290 | 8 | DOID:1826 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | CYP1B1 ABCA4 ABCA12 HTR3C LRRC4 RNF43 ABCB4 PTPRD PAN2 DLG3 PDZRN4 SHANK1 ABCC1 FLNC ABCB5 FRMPD2 TENM1 CTBP1 | 2.27e-04 | 702 | 290 | 18 | C0009402 |
| Disease | congenital adrenal hyperplasia (implicated_via_orthology) | 2.87e-04 | 3 | 290 | 2 | DOID:0050811 (implicated_via_orthology) | |
| Disease | hematopoietic progenitor cell antigen CD34 measurement | 2.87e-04 | 3 | 290 | 2 | EFO_0801667 | |
| Disease | mean fractional anisotropy measurement | 3.58e-04 | 95 | 290 | 6 | EFO_0008399 | |
| Disease | Colorectal Neoplasms | CYP1B1 ABCA4 ABCA12 RNF43 ABCB4 PTPRD ABCC1 FLNC ABCB5 CTBP1 | 4.50e-04 | 277 | 290 | 10 | C0009404 |
| Disease | Ullrich congenital muscular dystrophy 1 | 5.70e-04 | 4 | 290 | 2 | C0410179 | |
| Disease | Bethlem myopathy (is_implicated_in) | 5.70e-04 | 4 | 290 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy | 5.70e-04 | 4 | 290 | 2 | cv:C4551860 | |
| Disease | Bethlem myopathy | 5.70e-04 | 4 | 290 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 5.70e-04 | 4 | 290 | 2 | C1834674 | |
| Disease | mesothelin measurement | 5.70e-04 | 4 | 290 | 2 | EFO_0020565 | |
| Disease | retinoblastoma (is_implicated_in) | 5.70e-04 | 4 | 290 | 2 | DOID:768 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 5.70e-04 | 4 | 290 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | cys-gly, oxidized measurement | 9.44e-04 | 5 | 290 | 2 | EFO_0800122 | |
| Disease | treprostinil dose measurement | 9.44e-04 | 5 | 290 | 2 | EFO_0021489 | |
| Disease | Amelogenesis imperfecta type 1 | 9.44e-04 | 5 | 290 | 2 | cv:C0399367 | |
| Disease | Wilson disease (implicated_via_orthology) | 9.44e-04 | 5 | 290 | 2 | DOID:893 (implicated_via_orthology) | |
| Disease | primary hyperaldosteronism (is_implicated_in) | 9.44e-04 | 5 | 290 | 2 | DOID:446 (is_implicated_in) | |
| Disease | level of carboxypeptidase N subunit 2 in blood serum | 9.44e-04 | 5 | 290 | 2 | OBA_2041122 | |
| Disease | amino acid measurement | MYH10 ABCA12 RTN4R SLIT2 KCNMA1 C5 ITGA11 ARHGEF28 CAMK2G LINGO2 TMEM107 SLC6A2 TENM4 RASAL3 VCAN LRBA | 1.20e-03 | 678 | 290 | 16 | EFO_0005134 |
| Disease | Nonsyndromic Deafness | 1.23e-03 | 81 | 290 | 5 | C3711374 | |
| Disease | Chronic active hepatitis | 1.26e-03 | 22 | 290 | 3 | C0520463 | |
| Disease | Chronic Persistent Hepatitis | 1.26e-03 | 22 | 290 | 3 | C0149519 | |
| Disease | Hepatitis, Chronic | 1.26e-03 | 22 | 290 | 3 | C0019189 | |
| Disease | Cryptogenic Chronic Hepatitis | 1.26e-03 | 22 | 290 | 3 | C0524611 | |
| Disease | Cutis Laxa | 1.41e-03 | 6 | 290 | 2 | C0010495 | |
| Disease | complement component 1 q subcomponent-binding protein, mitochondrial measurement | 1.41e-03 | 6 | 290 | 2 | EFO_0020280 | |
| Disease | clubfoot (implicated_via_orthology) | 1.41e-03 | 6 | 290 | 2 | DOID:11836 (implicated_via_orthology) | |
| Disease | Immunologic Deficiency Syndromes | 1.44e-03 | 23 | 290 | 3 | C0021051 | |
| Disease | response to anticonvulsant | 1.53e-03 | 85 | 290 | 5 | GO_0036277 | |
| Disease | Dystonia | 1.61e-03 | 86 | 290 | 5 | C0013421 | |
| Disease | Renal Cell Carcinoma | 1.71e-03 | 128 | 290 | 6 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.71e-03 | 128 | 290 | 6 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.71e-03 | 128 | 290 | 6 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.71e-03 | 128 | 290 | 6 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 1.71e-03 | 128 | 290 | 6 | C1306837 | |
| Disease | Liver Cirrhosis, Experimental | SYNRG PDGFRB ACP5 ITGB6 ACOX2 PTPRD PYCR1 SLC39A6 DPP7 COL5A1 COL12A1 NAGK CAMK2D IFRD1 TKFC IGFALS FAM43A | 1.84e-03 | 774 | 290 | 17 | C0023893 |
| Disease | response to venlafaxine | 1.84e-03 | 25 | 290 | 3 | EFO_0006328 | |
| Disease | bipolar disorder (implicated_via_orthology) | 1.96e-03 | 7 | 290 | 2 | DOID:3312 (implicated_via_orthology) | |
| Disease | Amelogenesis imperfecta local hypoplastic form | 1.96e-03 | 7 | 290 | 2 | C0399367 | |
| Disease | dipeptidyl peptidase 2 measurement | 1.96e-03 | 7 | 290 | 2 | EFO_0020326 | |
| Disease | Cholangitis | 1.96e-03 | 7 | 290 | 2 | C0008311 | |
| Disease | ceroid-lipofuscinosis neuronal protein 5 measurement | 1.96e-03 | 7 | 290 | 2 | EFO_0802390 | |
| Disease | protocadherin alpha-7 measurement | 1.96e-03 | 7 | 290 | 2 | EFO_0801973 | |
| Disease | clusterin measurement | 1.96e-03 | 7 | 290 | 2 | EFO_0007655 | |
| Disease | Bleeding tendency | 1.96e-03 | 7 | 290 | 2 | C1458140 | |
| Disease | r-spondin-3 measurement | 1.96e-03 | 7 | 290 | 2 | EFO_0021878 | |
| Disease | heterogeneous nuclear ribonucleoproteins C1/C2 measurement | 1.96e-03 | 7 | 290 | 2 | EFO_0801675 | |
| Disease | brain connectivity measurement | MAGI1 ADGRV1 PNMA6F SLIT2 MET PLEC KPNA2 STRN3 ITGA11 TENM4 VCAN | 2.17e-03 | 400 | 290 | 11 | EFO_0005210 |
| Disease | Ischemic stroke, coronary artery disease | 2.17e-03 | 92 | 290 | 5 | EFO_0001645, HP_0002140 | |
| Disease | mean reticulocyte volume | CYP11B1 NT5C3A ARMC2 ABCB4 NUP205 ACOD1 PTPN11 IFRD2 N4BP2L2 CARNS1 BAG6 ABCC1 SPECC1 KIAA1217 HELZ2 ATM CDH6 | 2.55e-03 | 799 | 290 | 17 | EFO_0010701 |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.58e-03 | 139 | 290 | 6 | DOID:3908 (is_implicated_in) | |
| Disease | X-linked infantile spasms | 2.59e-03 | 8 | 290 | 2 | C4552072 | |
| Disease | chitinase-3-like protein 2 measurement | 2.59e-03 | 8 | 290 | 2 | EFO_0801471 | |
| Disease | Leydig cell tumor (is_marker_for) | 2.59e-03 | 8 | 290 | 2 | DOID:2696 (is_marker_for) | |
| Disease | sensorineural hearing loss (biomarker_via_orthology) | 2.59e-03 | 8 | 290 | 2 | DOID:10003 (biomarker_via_orthology) | |
| Disease | tyrosine-protein kinase JAK2 measurement | 2.59e-03 | 8 | 290 | 2 | EFO_0020825 | |
| Disease | Aqueductal Stenosis | 2.59e-03 | 8 | 290 | 2 | C2936786 | |
| Disease | calpastatin measurement | 2.59e-03 | 8 | 290 | 2 | EFO_0008065 | |
| Disease | SARS-CoV-2 antibody measurement, response to COVID-19 vaccine | 3.26e-03 | 62 | 290 | 4 | EFO_0803360, EFO_0803362 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 3.31e-03 | 9 | 290 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | retinal degeneration (is_implicated_in) | 3.31e-03 | 9 | 290 | 2 | DOID:8466 (is_implicated_in) | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 3.31e-03 | 9 | 290 | 2 | C3502809 | |
| Disease | protein FAM163B measurement | 3.31e-03 | 9 | 290 | 2 | EFO_0802936 | |
| Disease | attention function measurement | 3.52e-03 | 148 | 290 | 6 | EFO_0007636 | |
| Disease | hypertension | 3.54e-03 | 307 | 290 | 9 | EFO_0000537 | |
| Disease | adseverin measurement | 4.11e-03 | 10 | 290 | 2 | EFO_0801358 | |
| Disease | androstenedione measurement | 4.11e-03 | 10 | 290 | 2 | EFO_0007972 | |
| Disease | cancer antigen 125 measurement | 4.11e-03 | 10 | 290 | 2 | EFO_0010603 | |
| Disease | 2-aminobutyrate measurement | 4.11e-03 | 10 | 290 | 2 | EFO_0020017 | |
| Disease | transcription factor IIIb 90 kda subunit measurement | 4.11e-03 | 10 | 290 | 2 | EFO_0020778 | |
| Disease | mean arterial pressure | UBE2K CYP11B2 RXRA PTPN11 PTPRD SLC12A9 KCNMA1 COL5A1 KIAA1217 SNTG1 LRBA ATP12A | 4.13e-03 | 499 | 290 | 12 | EFO_0006340 |
| Disease | triglyceride measurement, response to selective serotonin reuptake inhibitor | 4.49e-03 | 34 | 290 | 3 | EFO_0004530, EFO_0005658 | |
| Disease | right ventricular systolic volume measurement | 4.87e-03 | 35 | 290 | 3 | EFO_0021815 | |
| Disease | asthma (implicated_via_orthology) | 4.87e-03 | 35 | 290 | 3 | DOID:2841 (implicated_via_orthology) | |
| Disease | cell growth regulator with EF hand domain protein 1 measurement | 4.99e-03 | 11 | 290 | 2 | EFO_0801461 | |
| Disease | 5-acetylamino-6-amino-3-methyluracil measurement | 4.99e-03 | 11 | 290 | 2 | EFO_0800951 | |
| Disease | neutrophil count, mean platelet volume, leukocyte count, erythrocyte count, mean corpuscular hemoglobin concentration, mean corpuscular volume, monocyte count, obsolete_red blood cell distribution width, basophil count, platelet count, eosinophil count | 4.99e-03 | 11 | 290 | 2 | EFO_0004305, EFO_0004308, EFO_0004309, EFO_0004526, EFO_0004528, EFO_0004584, EFO_0004833, EFO_0004842, EFO_0005090, EFO_0005091, EFO_0005192 | |
| Disease | Copper-Overload Cirrhosis | 4.99e-03 | 11 | 290 | 2 | C1876165 | |
| Disease | Pancreatic Ductal Adenocarcinoma | 4.99e-03 | 11 | 290 | 2 | C1335302 | |
| Disease | pancreatic cancer (is_implicated_in) | 5.06e-03 | 112 | 290 | 5 | DOID:1793 (is_implicated_in) | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 5.28e-03 | 36 | 290 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | hippocampal CA3 volume | 5.28e-03 | 36 | 290 | 3 | EFO_0009395 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LGFLNVTELVGALSD | 336 | Q8NAT2 | |
| NGLIESVELRGESAF | 361 | Q13569 | |
| LISGVTEFLNTEGEL | 961 | Q9UKU6 | |
| FIDALAQSGQEGILR | 51 | A6NGE7 | |
| IFSAGIGDVLEEVIR | 201 | Q9H0P0 | |
| AGLGIFEVRRVLDAS | 61 | O43414 | |
| DVLLVGSEAFVLLDG | 341 | Q9H0X4 | |
| FGQFEGDVIDLSLRL | 181 | P16452 | |
| LVAEERLSSGILGAI | 2456 | Q9HCE0 | |
| FDVERLTNILDGGAQ | 31 | Q99424 | |
| LEFGIDLDTRVALVG | 416 | Q9UG63 | |
| TLGVERFEEILQEAG | 41 | P04920 | |
| GFLLGEVRQEETFSI | 26 | Q15018 | |
| ERLGEAFDSQLVIGV | 166 | Q93034 | |
| ALRIIVRIGSGFDNI | 91 | Q13363 | |
| FLIGINEESVEGTAI | 3071 | P13611 | |
| ITGEALVGFLSDLGR | 1571 | P78363 | |
| RTIQDLGIGTFRDLA | 346 | Q9UGI9 | |
| LGIGTFRDLAVVLET | 351 | Q9UGI9 | |
| VGESLRLLGNTFVAL | 326 | P46379 | |
| VTGEFLELDLNTLVG | 371 | P59827 | |
| ELGLRAVALGFEDTE | 81 | O43306 | |
| VGSIEIFRFADGLDI | 31 | Q2M3G0 | |
| EVLSDRIAFLEQGGL | 1541 | Q86UK0 | |
| RLTFSGLLNALDGVA | 306 | Q9Y276 | |
| DAIGLEGFSVIIAQL | 306 | Q9Y3Q7 | |
| DGILEAVRVFGNLSQ | 691 | Q8NEN0 | |
| NSIRIDGDITLGGLF | 41 | Q14833 | |
| SFGDRVLLAGADVNL | 186 | Q9NUQ8 | |
| GFLILEEGETAAAIN | 2891 | Q8WXG9 | |
| DVDLVLFGGRLLAAF | 611 | A5YM72 | |
| RNLLLAFEAAESVGI | 1021 | Q5M775 | |
| AAVGNFELVSLLLER | 696 | A6QL63 | |
| NEIGSEETLLFLTVG | 331 | Q9BTE6 | |
| TVSLLLQGRGDAFTI | 16 | Q8WXA8 | |
| ERSFEGLGQLEVLTL | 331 | P35858 | |
| IGIFSDGDSREINLL | 341 | Q008S8 | |
| ILDDISRFDIQQGGA | 76 | Q6MZZ7 | |
| SQVIEGTIVLFLEDG | 36 | Q8N6M6 | |
| LSDNIISGGLEVLAE | 71 | Q9BTT0 | |
| ELARDLLEFLGSVNG | 621 | O43299 | |
| LLGATAIEDRLQDGV | 731 | O60423 | |
| TDGIGFAIARRLAQD | 41 | Q9BTZ2 | |
| GDIALLELENSVTLG | 556 | P00736 | |
| SFRTLVGLLGIEAAL | 261 | Q6IPU0 | |
| TALIILVGIGADDAF | 561 | Q96F81 | |
| IADGSRFILLEGSQL | 421 | O14525 | |
| GDLFVLRNFIIGTSD | 571 | Q8TBY9 | |
| IRELGFGATVIENAD | 546 | Q04656 | |
| VLLSGAEIFAELGEV | 261 | Q14894 | |
| EGFLLALTQGREIQA | 281 | Q9UJ70 | |
| GSAVLGRVALALEEL | 376 | Q86YV0 | |
| GLITAGAQLVELDLS | 106 | P46060 | |
| DVLFRLLLIGDSGVG | 6 | P59190 | |
| VLERENDTLGFNIIG | 226 | Q6ZMN7 | |
| ALEQDAVFGLESLLV | 381 | Q9NVH2 | |
| LDQDRLALGTEEGLF | 1101 | Q6DT37 | |
| LGEALGAVELSLSEF | 1276 | Q6DT37 | |
| LEVSISDGLFLSLGL | 36 | Q01726 | |
| SDGLFLSLGLVSLVE | 41 | Q01726 | |
| NGSGVSVLLELARLF | 241 | Q969V3 | |
| FDIGELAAVELLLAG | 101 | Q92621 | |
| GTTFLIERAQDLDVG | 151 | Q9Y5E7 | |
| ESGGFRSLLINAVEA | 246 | P32322 | |
| GSDRNFVIDRIGDIL | 921 | Q8N1W1 | |
| VEERLAGATLLIFAN | 111 | P36404 | |
| SILGNVTELLLAGVD | 306 | O15528 | |
| DSLVEAVLISEGLGL | 1896 | O60840 | |
| LADAEGDVFRGLQVV | 131 | Q02252 | |
| IGDLVGLDAEFVTLN | 971 | Q504Q3 | |
| TDGIGFAIARRLAQD | 41 | Q6PKH6 | |
| LGVLEEARFFGIDSL | 166 | Q7L273 | |
| AARILFELGVGTIDA | 221 | Q17RR3 | |
| IAFADLITVDEGGRA | 1836 | Q86XX4 | |
| QRFGEGLLEAELAAL | 31 | O14558 | |
| LVEFQGRTLGALESL | 586 | O95460 | |
| SVLEVFEGREDSILG | 226 | P43357 | |
| EFLDLEQSGTLLEVG | 166 | Q96QZ7 | |
| IFGDVSSALIGLRNL | 846 | Q12791 | |
| RSGEGDFELVLILSG | 271 | P78508 | |
| ESILLAIALLEGGNT | 1831 | Q14643 | |
| FEAQIAGLRGQLEAL | 141 | P08729 | |
| ELGLGELLEEFSRTQ | 26 | Q8NCE2 | |
| VAVAGGRLEEVSFLQ | 186 | Q96S65 | |
| GVQVDLEARDFEGLT | 141 | Q8NI38 | |
| FLLELQVISLESGDA | 91 | P40933 | |
| LVLELVTGGELFDRI | 116 | Q16566 | |
| FIRQIGVLLGVLDSD | 811 | Q8IZA0 | |
| ASIVTGVEEGRLIFD | 771 | P54707 | |
| ASIVTGVEEGRLIFD | 756 | P05023 | |
| AAFLDVVIGGRAVET | 376 | Q14C86 | |
| VAVILNEFGEGSALE | 71 | Q8IUF1 | |
| VAVILNEFGEGSALE | 71 | Q9BRT8 | |
| NGITVFGTRILDEEV | 201 | P12107 | |
| LSQVRFLVLDEADGL | 361 | Q92499 | |
| SLINEAFRILGEGIA | 626 | Q08426 | |
| LDERQVLLGAVGAFD | 411 | P38570 | |
| DTDRFVLLVSGLGLG | 191 | P49005 | |
| VIRDVGDESFQVGIL | 591 | Q16549 | |
| LGARAALVEFAEGLN | 56 | A0A0J9YX94 | |
| RLTITGENLGLRFED | 881 | Q9UIW2 | |
| ELEVLGDTEGLNLSF | 376 | P18564 | |
| VDTLGIFGDILVEAV | 166 | Q96DT0 | |
| AAELGAELLGEATIF | 76 | Q9H6K4 | |
| GVTSAGLVQEEIRFL | 746 | Q86W56 | |
| SEGLEIVFRVGLALL | 346 | O60447 | |
| QLRAGVEEQEGLLSF | 1411 | Q92817 | |
| ARDAGEGLLTVQILD | 1566 | Q14315 | |
| GTAVELLDVFLGLET | 201 | Q8N2G8 | |
| LAQVIVSRGGRFLEA | 371 | Q49A26 | |
| FAVLGEGLVQTVEAR | 1126 | Q9H6R4 | |
| FGNEVALALGEVLRL | 286 | Q0VAA2 | |
| GLAFIELVNEGRLLS | 1871 | P50851 | |
| RNRITEVGLEGFLAT | 481 | Q8N4P6 | |
| LIERNAFDGLASLVE | 256 | Q9HBW1 | |
| TLLEGFAGVEEAREQ | 771 | P35658 | |
| TVLGDGTLEIRFAQD | 461 | Q7L985 | |
| DLLVTGDNGDFTLRL | 306 | P18627 | |
| ILDFLRGGDVFTRLS | 151 | Q9UK32 | |
| RLLFIIDGFDDLGSV | 356 | P59047 | |
| GNITAATLRDDLFLV | 306 | Q96KJ4 | |
| GDLGLLEETLVIFTA | 266 | P15289 | |
| IVDALGDRIFSLEGT | 341 | Q9UKX5 | |
| AENLLLTRGVDGSFL | 16 | Q06124 | |
| VDQGRGFESILDVLS | 236 | Q6P9B6 | |
| LSSLQLGEGVEFDVL | 136 | P00973 | |
| RLSFFLLEQGAETGL | 491 | Q9UN70 | |
| GTFVGRIAQDLGLEL | 41 | Q9Y5H7 | |
| VLILGRGNSAFETAE | 216 | Q8IWF2 | |
| LVLNFRTGIVVEEGA | 141 | Q9P1Z3 | |
| FGVSLQELERQGLTE | 41 | O94988 | |
| LSAFIRNGLLEGLVE | 396 | Q6R327 | |
| QDVRLIEFDILGSGI | 226 | Q9UHB4 | |
| GVEFLGRAADALIAI | 41 | Q9NYA4 | |
| RGLDSDGSLLLDIVV | 4976 | Q96RW7 | |
| AEEALGAIRTVIAFG | 256 | P21439 | |
| GTFVGRIAQDLGLEL | 41 | Q9Y5I2 | |
| ELELLQFQVSARDGG | 526 | Q9Y5I2 | |
| DDFIGSGTEQVLLLF | 331 | Q8NB91 | |
| LGNIAGDGSVFRDLV | 186 | P52292 | |
| SLDVLRGNDETIGFE | 101 | Q9Y244 | |
| DVQLGDIILTATDGL | 211 | Q8NI37 | |
| LSRLENFTGLSLVGE | 186 | Q9BZG2 | |
| LEGQAFLGETGLDRT | 216 | Q2TBC4 | |
| IFLVLLGLSRAGTES | 16 | Q9Y5E9 | |
| ANLARDLGLGVEELS | 46 | Q9Y5E9 | |
| SDFVGQTVELGELRL | 26 | O14976 | |
| FIGDDDLLEILGQST | 1431 | Q8NCM8 | |
| RERTGEALGVLDFNI | 1256 | A4FU69 | |
| GAGTIRLEQDVFSAL | 216 | Q96IJ6 | |
| LQAIGELESIGELFS | 2176 | Q13315 | |
| ILQTIESGGLFVEDE | 3351 | Q4G0P3 | |
| VSLEEVLELLGTGFL | 261 | Q86XA9 | |
| RLAQVVDDGAFTAGL | 876 | Q86XA9 | |
| VNILIGRTDFRDGSI | 616 | A1L0T0 | |
| GFDQLRLEGLLCDVT | 81 | Q9P2N7 | |
| ARELRNVGVEVFSLG | 261 | Q99715 | |
| LEVGSDRGFLALIEG | 916 | Q9UFH2 | |
| DRGFLALIEGLVNDI | 921 | Q9UFH2 | |
| FLVTRDGLEDQLLAA | 3551 | Q9UFH2 | |
| IFEVIDLDGNGLLSL | 411 | A8K855 | |
| FLGEVDGAVLTQLLS | 911 | Q7Z3S7 | |
| IILAVNGRSTEGLIF | 1131 | Q68DX3 | |
| FTELLSDIGFAREGL | 1166 | Q6P158 | |
| RGQVLLIFSDGLQSE | 1301 | A8TX70 | |
| GLLVGEILSAVLSQE | 981 | P01031 | |
| SAGSRIEDGVLQFLV | 931 | P12111 | |
| GFNVIISRSLGIERE | 101 | Q7Z4T8 | |
| TIEASNLALFGERLG | 196 | P15538 | |
| GVVASFGRLLNEALI | 121 | Q96DP5 | |
| ERFLVVLNFGDVGLS | 561 | P08195 | |
| IIVSELLGSFADNEL | 431 | O14744 | |
| INGIIVFGTRILDEE | 201 | P20908 | |
| GDDLGEVLALSLRAF | 136 | Q96BJ8 | |
| EIVLERGNSGLGFSI | 131 | Q92796 | |
| AGESLALLFELARGI | 286 | O00458 | |
| LISDLGELSFGNDVR | 356 | Q8N2R8 | |
| RIAAGETIALLFELA | 341 | Q12894 | |
| IVDALGDRIFGLEGS | 346 | O75578 | |
| ASIVTGVEEGRLIFD | 746 | P13637 | |
| SGLDLLLAFNVGIEV | 126 | A6NK06 | |
| DELSIELENLFIGGT | 581 | Q15051 | |
| ILSGDGAGDLFIINE | 91 | P55285 | |
| ELVALLVRGSADGAF | 176 | Q16678 | |
| TIEASNLALFGERLG | 196 | P19099 | |
| LLGRFLEGVAAVLAT | 1291 | Q9NYQ7 | |
| ALFEESGLIRITLGA | 2811 | Q9NYQ7 | |
| RTVSGIFFGVELLEE | 156 | Q9NQC7 | |
| DQGFLLGRAVSTALV | 406 | Q9BYK8 | |
| FERTEVLAALIVGGI | 141 | P31431 | |
| GRDIFLLQALFGAVD | 371 | Q9NSA0 | |
| LDALLQTARTEGIFG | 251 | Q3KQZ1 | |
| GVGAIFDRVLTELVS | 341 | P19793 | |
| AIIQGLIIDAFGELR | 4931 | P21817 | |
| LGSDVARALLEFAQG | 816 | O00411 | |
| FDLEGESGLVVRAIG | 226 | Q86YS7 | |
| LLGAGAGSTFIIDER | 81 | Q9H159 | |
| VAELAAERGALLVFA | 91 | Q9UHL4 | |
| DLVTGGELFEDIVAR | 91 | Q13555 | |
| LRLAEFLSVQLGAEE | 86 | Q96AC6 | |
| GILDIAGFEIFELNS | 456 | P35580 | |
| AENGFSLEEVLRLGG | 36 | Q03701 | |
| ADSGLREAQAFLGVL | 346 | Q14154 | |
| AVREAFETGGLEAAL | 196 | Q8WZA9 | |
| DLVTGGELFEDIVAR | 91 | Q13557 | |
| VEDLEGGIRNVLLAF | 321 | Q07820 | |
| VRLLGEVGTLQFAEL | 316 | P09619 | |
| VIEFDDGSGSVLRIQ | 71 | P23468 | |
| FSLAEGLRTVLGLIQ | 246 | Q9Y6K5 | |
| TILEADNRIGGRIFT | 86 | Q96RQ9 | |
| EFLLLGFSSLGEIQL | 31 | Q8NGX6 | |
| LTLGLFRINESAEGE | 1336 | P33527 | |
| FRINESAEGEIIIDG | 1341 | P33527 | |
| LIDSTGQRLRIADFG | 1376 | Q13233 | |
| RQIGASLNDDILFGV | 331 | P08581 | |
| IDAAAFTGLALLEQL | 96 | Q9BZR6 | |
| NDLSDFTALLVDIIG | 146 | C9JL84 | |
| DLVTGGELFEDIVAR | 91 | Q13554 | |
| IEDVATEGAGLVFIL | 376 | P23975 | |
| SDDVLLSVLGLGDLA | 431 | Q13033 | |
| DAIIRGGLTRFTDQL | 241 | Q9HCS7 | |
| EGLLSEGNTIRIEFT | 531 | Q9BYH1 | |
| GGTLVADVLTRFENL | 461 | Q7Z736 | |
| AAGILDLLQASEEVG | 761 | O75151 | |
| GLEVDVFLGALREDV | 121 | A6NEV1 | |
| LVVAEAEGSGELLRA | 771 | Q6IEE7 | |
| AEGSGELLRAELTIA | 776 | Q6IEE7 | |
| LIGIFGQERATALLE | 506 | Q6ZMZ3 | |
| AERVEALLAFGEGLA | 151 | Q8N205 | |
| DVFRQLSLEGSGLGV | 746 | Q9UMZ2 | |
| AGRVVAGQIFLDSEE | 51 | Q9UBV2 | |
| ALELQLGRLVDGDSF | 176 | B5MCY1 | |
| QRAELSGLLFIGDAI | 91 | Q9NSN8 | |
| GNETGILSEDALLRI | 61 | Q63ZE4 | |
| RLEDGAEGVFAITQL | 421 | P57071 | |
| FEILDRTREGAILSG | 201 | Q96ME1 | |
| GVTVVIVRDDLLGFA | 206 | Q9Y617 | |
| REELLAEFGSGTLDL | 3086 | P58107 | |
| REELLAEFGSGTLDL | 4151 | P58107 | |
| GGVDILLIETIFDTA | 186 | Q99707 | |
| ETFQAVLDGLDALLT | 76 | Q5VT98 | |
| LNLTLEGVFAGVAEI | 61 | Q68DV7 | |
| EAGDAIALLLGVVLS | 26 | A4D0T7 | |
| VEDGAFLLRQVGEAV | 751 | Q5T5P2 | |
| LEESSAFLIVDGGVR | 496 | Q6PI26 | |
| LVTFDLLGEDQLVLG | 711 | Q9Y4R8 | |
| LIGRQIFRFSEEGLV | 2021 | Q9UKZ4 | |
| ESGGFRSLLINAVEA | 246 | Q96C36 | |
| QTGFLEFILLGLSED | 6 | Q96RA2 | |
| LVQEAGEGILSERRF | 81 | O95785 | |
| LVTGGELFEDIVARE | 91 | Q9UQM7 | |
| RAIQFLLGFLLGSEE | 886 | Q01968 | |
| SRLSEEGIFLLANGL | 911 | O94855 | |
| DGFIVTLSLVELGLA | 836 | P35498 | |
| TLSLVELGLANVEGL | 841 | P35498 | |
| LVALAVGTLSGDAFL | 361 | Q13433 | |
| AGVGAIFDRVLTELV | 411 | P28702 | |
| VAVIAGNFELGELIR | 386 | Q9Y566 | |
| FASIVTGVEEGRLIF | 761 | Q13733 | |
| VLTTGEVFRLLEEEG | 271 | Q9H6Q4 | |
| LDVLVRARTGFLEQG | 216 | Q16281 | |
| LIGGALTSAGDRFEL | 756 | Q8TCY9 | |
| GLSLEEFSRFVDLEG | 386 | Q6B0B8 | |
| QLRVFGAGLLSSISE | 326 | P17752 | |
| LFAVTQAEEGARLLA | 11 | P43308 | |
| IFSLREVIQGSGVLD | 171 | P47901 | |
| FLLVLADGLRTGVTE | 271 | Q9H900 | |
| FVLRDTDTGALLFIG | 396 | P36955 | |
| LVELLVSGSLEGFES | 41 | Q9HC29 | |
| RAVGAGLAEVFQLVE | 86 | Q6SZW1 | |
| SNFISGAGILRLVEA | 261 | P28289 | |
| GSLLEQGALLEGTRF | 316 | Q8TB61 | |
| DIEEVSQGLLSLLGA | 6 | Q8NBT2 | |
| SVFEGLAVGLQRDRA | 191 | Q9NY26 | |
| ENFGLIDGRLTICTI | 76 | Q15005 | |
| LGEFNLGSTIVLIFE | 371 | Q9UG56 | |
| LELDVGLSREAQAGE | 1221 | Q9BXM0 | |
| GIRAEDLVIGALESA | 181 | Q96MI6 | |
| LTGRLVGALDAVLDS | 41 | O95759 | |
| IVGRADVGASLFFLL | 136 | Q8N394 | |
| LLGLVESVLDVFGAD | 136 | Q9BXP2 | |
| VLVADANGFTAGLRL | 431 | O94964 | |
| IEVLRFDDGGLLQTE | 71 | Q92545 | |
| AFSELVEILGDLLQG | 1161 | P35916 | |
| ALSVTLGLFAVELAG | 56 | Q6UX40 | |
| AAVAFGAEVGVRLAL | 6 | Q8NEB5 | |
| RDEGIVEAFLAGAVT | 21 | A8MPS7 | |
| RTVQILGADFILSLG | 56 | P13686 | |
| DLVTNGGISIILRFE | 961 | Q6N022 | |
| AGVGSIFDRVLTELV | 341 | P48443 | |
| DGFVLTRLLEVLSGE | 91 | Q9H254 | |
| VGNDSFIGLSSVRLL | 621 | O94813 | |
| EEALRLLDAQLATGG | 3931 | Q15149 | |
| TEGSLIIALGNEDAL | 376 | Q9P2J2 | |
| FTEQLGRFALVGEAL | 571 | Q6ZN44 | |
| IEGAGILLTRFASAQ | 126 | Q99595 | |
| LELSAEAFTLGGVLV | 136 | P0C7T8 | |
| LVDENFTELRGEIAG | 31 | P61086 | |
| TLEQFRELLEARGAG | 96 | O43149 | |
| NVEDDGLTGLLRLAT | 1781 | Q70CQ2 | |
| TAGLRISDGVVLFID | 216 | Q15029 | |
| GLSFLELGIIADATV | 271 | Q3LXA3 | |
| RTFLTDLGGGLLQVE | 76 | Q86YW5 | |
| VAAFGELRSLADQGI | 956 | A3KMH1 | |
| LLVTGAADGVIRLFD | 576 | A4D1P6 | |
| SFGIEVRGEDLTVAL | 1201 | Q6BDS2 | |
| VSRLGELGLVEFRDL | 26 | Q13488 | |
| LGETERFLSQVLGRV | 271 | Q13488 | |
| LGFAVSLLLGLAEQE | 151 | O43156 | |
| ELLSQAARILGSVDF | 4056 | Q5THJ4 | |
| ILLGQNRDGIVFSTD | 421 | Q92802 | |
| GDALDAIFTELGRIG | 1206 | Q5VTT5 | |
| RAIDLALLQFLGDGE | 771 | Q14957 | |
| ADGVLSLGELQELFS | 66 | Q96P71 |